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Abstract. A general and efficient synthesis of 4,9-dihydro-1H-carbazoles from 3-allenylmethylindoles is 
reported. The process, catalyzed by a cationic gold(I) complex, involves a formal C2H bond activation 
of the indole unit by reaction with allenes. The nature of the substituents at the allylic as well as the 
terminal position of the allene moiety has a crucial effect on the regioselectivity of the cyclization, 
which is also influenced by the catalyst and the solvent employed. Moreover, some evidence of the 
 2 
contribution of different reaction routes is provided which led us to propose a plausible multi-pathway 
mechanism consistent with all the results described. 
Introduction 
The carbazole unit is a key heterocyclic structure present in a broad range of natural products 
possessing biological activity
1,2
 and in molecules having interesting applications in materials science.
3-5
 
Therefore, numerous approaches for their preparation have been described.
1
 However, the synthesis of 
the related tetrahydro-
6-9
 and dihydrocarbazoles
10-13
 has received less attention. For instance, no efficient 
methodologies to access 4,9-dihydro-1H-carbazoles have been developed, even though this heterocyclic 
skeleton is found in diverse natural products such as dihydrotubingensins A-B (Figure 1).
14
 The scarce 
reported syntheses of such dihydrocarbazoles are limited to particular examples of [4+2] intra-
15
 or 
intermolecular
16-18
 cycloadditions of in situ generated indole-2,3-quinodimethanes with acetylenes, and 
ring-closing methathesis.
19
 
 
Figure 1. Naturally occurring 4,9-dihydro-1H-carbazoles. 
 
 
On the other hand, transition-metal-catalyzed cycloisomerization of enynes
20
 and functionalized 
allenes
21,22
 has become a powerful strategy for the synthesis of cyclic compounds. In this regard, gold-
catalyzed reactions of alkyne-functionalized indoles allow the construction of a wide range of hetero-
polycyclic frameworks.
23-33
 However, related cycloisomerizations of indoles with a tethered allene have 
been less studied.
34-36
 In particular, a gold-catalyzed hydroarylation of N-allenylmethylindoles that 
furnishes dihydro-pyrido[1,2-a]-1H-indoles has been described (Scheme 1a).
37
 Moreover, several 
 3 
cyclizations of 1-(indol-2-yl)-allenols (functionalized 2-allenylmethylindoles) that afford carbazoles 
have been developed using different metals such as Au,
38-40
 Pt
41-43
 or Pd
44
 (Scheme 1b). 
In this context, and taking advantage of our experience in the gold-catalyzed isomerization of 3-
propargylindoles that produce 2-(indol-3-yl)indenes (Scheme 1c),
45-48
 we envisioned that unexplored 3-
allenylmethylindoles could be suitable substrates for the development of a general and efficient 
synthesis of 4,9-dihydro-1H-carbazoles (Scheme 1d). 
 
SCHEME 1. Reported cycloisomerizations of allenylmethyl- and propargylindoles and proposed 
synthesis of dihydrocarbazoles. 
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Results and Discussion 
To our aim, we initially selected 3-(1-cyclopropyl-1-phenylhepta-2,3-dien-1-yl)-1-methyl-1H-indole 
1a (a disubstituted allene derivative) as model substrate. Preliminary essays conducted at rt in the 
presence of Ph3PAuNTf2 as catalyst afforded a complex mixture of compounds. Pleasantly, a clean 
cycloisomerization selectively occurred by setting up the reaction at –78 ºC and allowing the mixture to 
reach rt, thus affording a 1/2.3 mixture of regioisomers 2a and 3a (Table 1, entry 1). On the contrary, no 
evolution of the allene derivative was observed in reactions on the presence of others metal salts or 
Lewis acids such as PtCl2, GaCl3 or Sc(OTf)3. Interestingly, the formation of 3a implies a formal alkyl 
migration by breaking one and creating two new C–C bonds. The influence of the catalyst and reaction 
conditions in the process was then investigated. Same ratio of regioisomers (1/2.3) was obtained in 
reactions conducted at –50 ºC or at other temperatures between rt and –78 ºC. No reaction was observed 
either with Ph3PAuCl or AgNTf2
 
(entries 2–3), whereas a messy reaction and a decrease in the 
selectivity was observed with XPhosAuNTf2 (entry 4). Remarkably, a switch in the regioselectivity 
occurred using an equimolecular mixture of PPh3AuCl and AgNTf2 as catalyst (entry 5). Analogous 
experiments using catalysts derived from NHC or phosphite ligands also produced cycloadduct 2a as the 
major isomer in comparable ratios (entries 7–9). The switch in the regioselectivity (entry 1 vs 5) could 
be associated with a non innocent presence of the silver salt.
49
 This assumption was confirmed with an 
experiment conducted with the combination PPh3AuNTf2/AgCl as catalyst that also switched the 
regioselectivity to give in this case a 1.2/1 ratio of 2a/3a (entry 6). These results support the complexity 
of the gold/silver catalysis mechanisms pointed out by Shi.
49
 
On the other hand, although a minor influence of the catalyst counterion in the outcome of the process 
was determined, the product ratio 2a/3a could be slightly improved using a triflate anion (entry 10 vs 
entries 11–13). In contrast, the solvent has a crucial effect in the regioselectivity. Thus, reactions 
catalyzed by Ph3PAuNTf2 and conducted in CH2Cl2, DCE or trifluorotoluene gave 3a as major isomer 
while analogous experiments conducted in non-halogenated solvents such as DME, THF, MeOH or 
toluene switched the selectivity to 2a (entries 1, 1415 vs 1619). A similar trend was found in reactions 
 5 
catalyzed by (PhO)3PAuCl/AgNTf2 (entry 8 vs 20). Furthermore, by using this phosphite derived gold 
complex and changing the catalyst counterion to triflate, that we had previously observed that favoured 
the formation of 2a, we were able to nearly exclusively obtain dihydrocarbazole 2a (entry 21). 
 
TABLE 1. Cycloisomerization of 3-allenylmethylindole 1a: Effect of the reaction conditions on 
the selectivity. 
 
entry catalyst solvent 2a / 3a 
a
 
1 Ph3PAuNTf2 CH2Cl2 1 / 2.3 
2 Ph3PAuCl CH2Cl2 - 
3 AgNTf2 CH2Cl2 - 
4 XPhosAuNTf2 CH2Cl2 1 / 1.2
 b
 
5 Ph3PAuCl/AgNTf2 CH2Cl2 2 / 1 
6 Ph3PAuNTf2/AgCl CH2Cl2 1.2 / 1 
7 IPrAuCl
c
/AgNTf2 CH2Cl2 2.2 / 1
 b
 
8 (PhO)3PAuCl/AgNTf2 CH2Cl2 2.6 / 1 
9 (2,4-(tBu)2C6H3O)3PAuCl/AgNTf2 CH2Cl2 2.1 / 1 
10 Ph3PAuCl/AgOTf CH2Cl2 2.8 / 1 
11 Ph3PAuCl/AgBF4 CH2Cl2 2.5 / 1 
12 Ph3PAuCl/AgOTs CH2Cl2 2.5 / 1 
13 Ph3PAuCl/AgSbF6 CH2Cl2 2.3 / 1 
14 Ph3PAuNTf2 DCE 1/ 1.9 
15 Ph3PAuNTf2 C6H5CF3 1 / 1.4 
16 Ph3PAuNTf2 DME 4.3 / 1 
17 Ph3PAuNTf2 THF 4.3 / 1 
18 Ph3PAuNTf2 MeOH 4.3 / 1 
19 Ph3PAuNTf2 toluene 4.6 / 1 
20 (PhO)3PAuCl/AgNTf2 toluene 6.9 / 1 
21 (PhO)3PAuCl/AgOTf toluene >10 / 1 
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a
 Determined by 
1
H NMR of the crude mixture after complete conversion (4-6 h). 
b
 Several unidentified compounds were also formed. 
c
 IPr = 1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene. 
 
Notably, our studies on reaction conditions show that an appropriate selection of catalyst and solvent 
allows the selective formation of both dihydrocarbazole isomers 2a and 3a from allenylmethylindole 1a: 
the combination (PhO)3PAuCl / AgOTf / toluene (Method A) selectively produces 2a whereas 
PPh3AuNTf2 / CH2Cl2 (Method B) predominantly furnishes 3a. 
Once Method A and Method B were established as the best conditions for obtaining 
dihydrocarbazoles 2a and 3a selectively, we decided to explore the influence of the starting substrate in 
the process outcome and the scope of both cycloisomerizations. Initially, we prepared various 
allenylmethylindoles 1 possessing a quaternary allylic carbon and a di- or trisubstituted allene moiety 
(R
1
, R
2
, R
3
 ≠ H) from 3-propargylindoles 4 and 5. These derivatives were easily accessible from simple 
and commercially available N-methyl indole, carbonyl and alkyne compounds applying our previously 
developed Brønsted acid-catalyzed direct substitution of propargylic alcohols (Scheme 2a).
45,50,51
 Then, 
using Myers conditions,
52
 i.e., the addition of alkynol 4 to a mixture of PPh3 and DIAD (diisopropyl 
azodicarboxylate), followed by the addition of NBSH (o-nitrobenzenesulfonylhydrazide),
53
 allene 
derivatives 1a-i were obtained in good yields (Scheme 2b). On the other hand, benzyl-functionalized 
acetylenes 5 were efficiently transformed in the corresponding allenes 1j-m by base promoted 
isomerization using KOH
54
 or t-BuLi (Scheme 2c). 
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SCHEME 2. Synthesis of allenylmethylindoles 1a-i, j-m. 
 
 
Having synthesized allenylmethylindoles 1a-m bearing different substituents (R
1
-R
4
), their reactions 
were investigated under both conditions A (Table 2) and B (Table 3). As previously observed for 1a 
(Table 2, entry 1), reactions under method A of disubstituted allenes 1b-k (R
4
 = H) (Table 2, entries 
211) as well as trisubstituted allene derivatives 1l-m (R4 ≠ H, entries 1213) bearing aryl, linear- or 
branched-alkyl groups at both allylic and terminal allene positions essentially or exclusively afforded 
regioisomer 2. Therefore, using method A, a series of highly substituted 4,9-dihydro-1H-carbazoles 2a-
m were regioselectively obtained in good yields. In all the reactions displayed in Table 2 as well as in 
the ones described later in this paper (depicted in Table 3 and Schemes 45), the major regioisomer was 
 8 
obtained as a ca. 1/1 mixture of diastereomers and could be easily isolated from the minor regioisomer.
55
 
Furthermore, the structure of the final products was established by NMR experiments. 
 
TABLE 2. Cycloisomerization of 3-allenylmethylindoles 1a-m using Method A: Regioselective 
synthesis of 4,9-dihydro-1H-carbazoles 2.
a
 
 
entry 1 R
1
 R
2
 R
3
 R
4
 2 yield (%)
b
 
1 1a Ph c-Pr n-Pr H 2a 78 
2 1b Ph Ph n-Pr H 2b 91 
3 1c c-Pr c-Pr n-Pr H 2c 57 
4 1d Me c-Pr n-Pr H 2d 64 
5 1e Me Me n-Pr H 2e 80 
6 1f Ph c-Pr Me H 2f 57
c
 
7 1g 4-ClC6H4 c-Pr Me H 2g 66
c
 
8 1h Ph i-Pr Me H 2h 76
c
 
9 1i Ph c-Pr i-Pr H 2i 70
c
 
10 1j Ph c-Pr Ph H 2j 80 
11 1k Ph Ph Ph H 2k 78 
12 1l Ph c-Pr Ph Me 2l 86 
13 1m Ph c-Pr Ph Ph 2m 25
d
 
a
 Reactions required 4-6 h to complete and products 2 were 
exclusively formed (regioselectivity >20/1) unless otherwise stated. 
b
 Isolated yield. 
c
 Ratio 2/3: 3.6/1 (entry 6), 3.8/1 (entry 7), 6.7/1 
(entry 8), 5.0/1 (entry 9). 
d
 41% conversion.
 
 
In contrast, parallel experiments conducted under method B revealed a significant influence of the 
substitution pattern of the substrate in the selectivity of the cycloisomerization. Thus, whereas the 
formation of dihydrocarbazole 3a from the model substrate 1a was favoured (Table 3, entry 1), reactions 
 9 
of related derivatives 1b-e (R
3
 = n-Pr) mainly afforded dihydrocarbazoles 2b-e with variable quantities 
of 3b-e depending on the substitution at the allylic carbon (Table 3, entries 25). In this sense, the 
presence of an aromatic group at this position seems to be necessary to obtain regioisomer 3 in 
appreciable amounts. Moreover, the steric hindrance of the R
3
 substituent has a crucial effect on the 
product distribution as we determined analyzing reactions of substrates 1f,a,i (with R
3
 = Me, n-Pr, and i-
Pr groups, respectively). We can conclude that, under conditions B, the selectivity of the isomerization 
to dihydrocarbazole 3 could be notably improved by increasing the bulkiness of the alkyl group located 
at the terminal sp
2
 allene carbon atom (Table 3, entries 6 vs 1 vs 9). On the contrary, isomers 2 appear to 
be totally favoured for substrates 1j-k bearing R
3
 = Ph (Table 3, entries 1011). In addition, reactions of 
trisubstituted allene derivatives 1l-m (R
3
, R
4
 ≠ H) occurred mostly to decomposition under these 
conditions (Table 3, entries 1213). Therefore, among the highly substituted allene derivatives 1a-m 
investigated under conditons B only 1a and 1i afford useful synthetic yields of the corresponding 4,9-
dihydro-1H-carbazoles 3a and 3i (Table 3, entries 1 and 9) whereas dihydrocarbazoles 3b,f-g were 
obtained in modest yields (Table 3, entries 2 and 6 
 
TABLE 3. Effect of the structure of the substrate on the selectivity of the cycloisomerization of 
3-allenylmethylindoles 1a-m using Method B. 
 
entry 1 R
1
 R
2
 R
3
 R
4
 2 / 3 
a
 3 yield (%)
b
 
1 1a Ph c-Pr n-Pr H 1/2.3 3a 65 
2 1b Ph Ph n-Pr H 2.1/1 3b 20 
3 1c c-Pr c-Pr n-Pr H 7.0/1 3c – 
4 1d Me c-Pr n-Pr H >10/1 3d – 
5 1e Me Me n-Pr H >20/1 3e – 
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6 1f Ph c-Pr Me H 1.3/1 3f 24 
7 1g 4-ClC6H4 c-Pr Me H 1.5/1 3g 28  
8 1h Ph i-Pr Me H 4.4/1 3h – 
9 1i Ph c-Pr i-Pr H 1/>10 3i 72 
10 1j Ph c-Pr Ph H >20/1 3j – 
11 1k Ph Ph Ph H >20/1 3k – 
12 1l Ph c-Pr Ph Me –
c
 3l – 
13 1m Ph c-Pr Ph Ph –
c
 3m – 
a
 Determined by 
1
H NMR of the crude mixture. Reactions required 4-6 h and 
only products 2 and/or 3 were formed unless otherwise stated. 
b
 Isolated yield. 
c
 Decomposition was observed.
 
 
Next, we turned our attention to the isomerization of substrates 1n-r possessing a terminal allene that 
were also easily prepared using Myers methodology.
52
 Preliminar experiments conducted with 
allenylmethylindole 1n gave dyhydrocarbazole 3n as major regioisomer, in moderate 3/2 ratio, 
regardless of the method used (Scheme 3). Further attemps to optimize the reaction conditons in order to 
increase the regioselectivity to 3n or to favour the formation of 2n were unsuccessful. 
 
SCHEME 3. Cycloisomerization of allenylmethylindole 1n. 
 
 
Nevertheless, using method B, dihydrocarbazole 3n could be isolated in a reasonable 60% yield 
(Scheme 4). In the same way, 4,9-dihydro-1H-carbazoles 3o-r were obtained in a regioselective fashion, 
although usually in modest ratio, and isolated in moderate to good yields from the corresponding starting 
allenes 1o-r (Scheme 4).
55
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SCHEME 4. Synthesis of 4,9-dihydro-1H-carbazoles 3n-r from allenylmethylindoles 1n-r bearing 
a terminal allene moiety.
a 
 
a
 All reactions were conducted under Method B with the exception of substrate 3p which was prepared 
using Method A. In brackets regioisomeric ratio 2/3 and isolated yield of dihydrocarbazole 3.
 
 
To complete the study of the influence of the substitution in the process outcome, 
allenylmethylindoles 1s-v with a tertiary or secondary allylic carbon instead a quaternary one were 
prepared. Notably, reactions of all these substrates cleanly and exclusively produced 4,9-dihydro-1H-
carbazoles 2s-v in good yields regardless of the reactions conditions employed or the substitution of the 
starting substrate 1 (Scheme 5). Unexpectedly, these dihydrocarbazoles were completely stables and no 
spontaneous dehydrogenation reaction to give the corresponding carbazoles was observed under the 
reaction conditions or during the purification. Moreover, it is worth to mention that even for 
allenylmethylindoles 1t-u, having a terminal allene moiety, the formation of 4,9-dihydro-1H-carbazoles 
3t-u was totally suppressed using boths methods A and B. These results are in sharp contrast to 
reactions of substrates 1n-r, possesing a terminal allene moiety and a quaternary allylic carbon, that 
 12 
afford 3 as major regioisomer in spite of the method used (Scheme 4). On the other hand, the structure 
of the final products 2s-v was again established by NMR experiments and confirmed by X-ray 
diffraction analysis of 2u.
56
  
 
SCHEME 5. Synthesis of 4,9-dihydro-1H-carbazoles 2s-v from allenylmethylindoles 1s-v 
possessing a tertiary or secondary allylic carbon.
a 
 
a
 Reactions were conducted under Method A [(PhO)3PAuCl/AgOTf (5 mol%), toluene] with the 
exception of substrate 2u which was prepared using Method B [Ph3PAuNTf2 (5 mol%), CH2Cl2]. 
 
This comprehensive study revealed that 3-allenylmethylindoles 1 bearing a di- or tri-substituted allene 
moiety regioselectively react to produce 4,9-dihydro-1H-carbazoles 2 in good yields and, on the other 
hand, that the formation of compounds 3 from allenylmethylindoles 1 bearing a quaternary center at the 
allylic carbon was favoured using method B provided that the terminal carbon of the allene was 
unsubstituted or just monosubstituted with a bulky alkyl group. The newly synthesized heterocycles 2 
could be mono-, di-, tri- and tetrasubstituted at the sp
3
 carbons of the tricyclic core and, moreover, the 
substitution includes aryl and linear- or branched-alkyl at both positions. In addition, regioisomeric 4,9-
 13 
dihydro-1H-carbazoles 3a,i,n-r were synthesized in moderate to good yields from the corresponding 
starting substrates 1a,i,n-r in a regioselective fashion using method B. 
A mechanism that would explain the formation of products 2 and 3 is illustrated in Scheme 6. The 
reaction would be initiated by coordination of the catalyst to the allene followed by an intramolecular 
attack of the indole that may occur to both activated carbons of intermediate 6 to furnish spirocycle 
species 7 (path a) or 8 (path b).
57
 The cyclopropane containing intermediate 7 would evolve by a 5-exo 
cyclization to give gold carbenoid 9 whose rearomatization would trigger a sequence of cyclopropane 
ring opening/protodemetalation to yield dihydrocarbazole 2 through vinyl gold intermediate 10. On the 
other hand, at least three different evolutions of intermediate 8 could be possible. One of them, the alkyl 
migration of the carbon supporting R
3
 and R
4
 (path b1), would also account for the formation of isomer 
2 via intermediates 11 and 10. However, the alternative 1,2-alkyl shift (path b2) and subsequent 
protodemetalation on cationic gold interemediate species 12 would render regioisomer 3. Moreover, a 
related stepwise pathway b3 assisted by the metal that involves the formation of gold carbenoid species 
13 would be also plausible. This intermediate would undergo an indole nucleophilic addition on the gold 
carbenoid giving rise to new spirocyclic derivative 14, which by a sequence of cyclization/ring 
opening/protodemetalation would afford dihydrocarbazole 3. Taking into account the data exposed 
above we consider at this point that most probably, and depending on the catalyst and the substrate used, 
all the proposed pathways could be operative. 
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SCHEME 6. Proposed mechanism.
 
 
 
In fact, we have obtained some evidence for the viability of paths a and b3. As illustrated in Scheme 5, 
reactions of 1t-v selectively afford products 2t-v that, based in our proposal, should be formed through 
pathway a and/or b1 (Schemes 67). As shown in Scheme 7, if path b1 would be the only operative route 
it would imply an opposite selective migration of benzylic vs primary alkyl group in the corresponding 
intermediates 8 (compare intermediates 8t,u vs 8v). Therefore, path a must be the running mechanism 
for at least one of this type of substrates. Furthermore, the effect of steric bulk at R
3
 using method B 
conditions, i.e. the improved selectivity to compound 3 by increasing the steric hindrance at R
3
 (Me vs 
n-Pr vs i-Pr, Table 3, entries 6, 9, and 1, respectively), also account for the viability of path a. With a 
bulkier substituent at R
3
, it seems that intermediate 8 would prefer to evolve through path b1 to release 
steric hindrance at the transition state. That would lead to 2, which is not consistent with our 
observations. Therefore, path a would be more likely to explain these results, which would be logical 
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considering that the formation of 7 from 6 should be favoured over the formation of 8 with an increased 
steric bulk at R
3
. 
On the other hand, pathway b3 is partially working in the case of 1q as pointed out by the minor 
formation of indene 15 that could take place via an iso-Nazarov cyclization of the corresponding 
intermediate 13q (Scheme 8). This cyclization could also be considered as a Friedel-Crafts type reaction. 
 
SCHEME 7. Evidence of viability of pathway a: Cycloisomerization of allenylmethylindoles 1t-v. 
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SCHEME 8. Evidence of viability of pathway b3: Formation of indene 15 in the reaction of 
allenylmethylindole 1q. 
 
 
Conclusions 
In conclusion, we have described a gold(I)-catalyzed cyclization of 3-allenylmethylindole derivatives 
allowing access to elusive 4,9-dihydro-1H-carbazoles. The process, whose regioselectivity seems to be 
influenced by both the substrate and the reaction conditions (catalyst and solvent), involves a formal 
C2H bond functionalization of the indole unit with allenes. The synthetic utility of this transformation 
is ilustrated with the preparation of several new dihydrocarbazoles with a wide variety of substitution 
patterns in usually good yields. Moreover, a plausible mechanism that involves different pathways has 
been proposed and some insight into the viability of two of these possible routes has been obtained.  
 
Experimental Section 
All reactions involving air sensitive compounds were carried out under a N2 atmosphere (99.99%). All 
glassware was oven-dried (120 °C), evacuated and purged with nitrogen. All common reagents, catalysts 
and solvents were obtained from commercial suppliers and used without any further purification. 
Solvents were dried by standard methods. Hexane and ethyl acetate were purchased as extra pure grade 
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reagents and used as received. Gold and silver catalysts were purchased from Aldrich or Strem. TLC 
was performed on aluminum-backed plates coated with silica gel 60 with F254 indicator; the 
chromatograms were visualized under ultraviolet light and/or by staining with a Ce/Mo reagent and 
subsequent heating. Rf values are reported on silica gel. Flash column chromatography was carried out 
on silica gel 60, 230-240 mesh. Deactivated silica gel was obtained by stirring with an aqueous K2HPO4 
solution for 3 h and subsequent filtration and drying at 140 ºC for 3 days. NMR spectra were measured 
on 300 MHz and 400 MHz spectrometers. 
1
H NMR: splitting pattern abbreviations are: s, singlet; bs, 
broad singlet; d, doublet; t, triplet; at, apparent triplet; aq, apparent quartet; sept, septet; dd, doublet of 
doublets; dt, doublet of triplets; td, triplet of doublets; ddd, doublet of doublets of doublets; ddt, doublet 
of doublets of triplets; dtd, doublet of triplets of doublets; tdd, triplet of doublets of doublets; m, 
multiplet; the chemical shifts are reported in ppm using residual solvent peak as reference. 
13
C NMR 
spectra were recorded at 75.4 MHz or 100.6 MHz using broadband proton decoupling and chemical 
shifts are reported in ppm using residual solvent peaks as reference and the multiplicities were 
determined by DEPT experiments. High resolution mass spectra (HRMS) were recorded using EI at 
70eV on an instrument equipped with an ion trap analyzer. Melting points were measured using open 
capillary tubes and are uncorrected. GC-MS and low resolution mass spectra (LRMS) measurements 
were recorded on an instrument equipped with a HP-5MS column. 
Synthesis of allenylmethylindoles 1: 
The starting allenylmethylindoles 1a-i,n-v were prepared using Myers methodology,
52
 whereas 1j-k 
were obtained from the corresponding alkyne derivatives by isomerization with KOH.
54
 
Allenylmethylindoles 1l-m were synthesized using the following base promoted procedure: To a 
solution of the appropriate alkyne 5 (2 mmol) in THF (2 mL) at 78 ºC was added dropwise t-BuLi (3 
equiv., 6 mmol, 3.5 mL of 1.7 M solution in pentane). After stirring the mixture for 1 h, the temperature 
was allowed to increase to 65 ºC (for 1h). At this temperature the reaction was quenched by the 
addition of 2 mL of THF/water (1:1) and was allowed to reach room temperature. The mixture was 
extracted with Et2O, the organic phase was dried over anhydrous NaSO4 and the solvent removed under 
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vacuum. The resulting crude residue was purified by column chromatography using hexane/Et2O (40:1) 
as eluent to obtain the corresponding allenylmethylindoles 1l-m in the yields reported bellow. 
Characterization and spectroscopic data for allenylmethylindoles 1: 
3-(1-Cyclopropyl-1-phenylhepta-2,3-dien-1-yl)-1-methyl-1H-indole (1a): Colourless oil; yield = 
80% (273 mg); isolated as a ~1:1 mixture of diastereoisomers; Rf = 0.30 (hexane/AcOEt, 20:1); 
1
H 
NMR (CDCl3, 300 MHz):  = 0.120.37 (m, 4H), 0.450.65 (m, 4H), 0.85 (t, J = 7.4 Hz, 3H), 0.91 (t, J 
= 7.5 Hz, 3H), 1.201.46 (m, 4H), 1.671.80 (m, 2H), 1.812.08 (m, 4H), 3.81 (s, 6H), 5.095.19 (m, 
2H), 5.725.79 (m, 1H), 5.805.86 (m, 1H), 6.856.93 (m, 2H), 6.947.05 (m, 2H), 7.117.35 (m, 
12H), 7.377.47 (m, 4H). 13C NMR (75.4 MHz, CDCl3):  = 1.79 (CH2), 1.82 (CH2), 2.0 (CH2), 2.1 
(CH2), 13.80 (CH3), 13.85 (CH3), 20.0 (CH), 20.5 (CH), 22.68 (CH2), 22.71 (CH2), 31.2 (CH2), 31.4 
(CH2), 32.9 (CH3, both isomers), 47.9 (C, both isomers), 93.3 (CH), 93.4 (CH), 98.3 (CH), 98.7 (CH), 
109.1 (CH), 109.2 (CH), 118.4 (CH), 118.5 (CH), 120.9 (C, both isomers), 121.1 (CH), 121.2 (CH), 
121.8 (CH), 121.9 (CH), 126.1 (CH, both isomers), 126.8 (C), 127.0 (C), 127.4 (2 × CH), 127.5 (2 × 
CH), 127.8 (CH), 128.0 (CH), 128.8 (2 × CH), 129.1 (2 × CH), 137.70 (C), 137.73 (C), 144.8 (C), 145.5 
(C), 203.7 (C), 203.9 (C). LRMS (70 eV, EI): m/z (%) 341 (M
+
, 61), 260 (100). HRMS calcd for 
C25H27N, 341.2144; found, 341.2147. 
3-(1,1-Diphenylhepta-2,3-dien-1-yl)-1-methyl-1H-indole (1b): Colourless oil; yield = 70% (264 
mg); Rf = 0.16 (hexane/diethyl ether, 20:1); 
1
H NMR (CDCl3, 300 MHz):  = 0.73 (t, J = 7.3 Hz, 3H), 
1.031.25 (m, 2H), 1.721.96 (m, 2H), 3.69 (s, 3H), 5.01 (dt, J = 7.6, 6.4 Hz, 1H), 6.18 (ddd, J = 6.4, 
3.0, 2.6 Hz, 1H), 6.34 (s, 1H), 6.926.99 (m, 1H), 7.177.36 (m, 13H). 13C NMR (75.4 MHz, CDCl3):  
= 13.6 (CH3), 22.6 (CH2), 31.0 (CH2), 32.8 (CH3), 54.4 (C), 94.0 (CH), 99.7 (CH), 109.2 (CH), 118.6 
(CH), 121.3 (CH), 121.4 (C), 122.9 (CH), 126.2 (2 × CH), 127.4 (C), 127.62 (2 × CH), 127.65 (2 × 
CH), 129.49 (CH), 129.52 (2 × CH), 129.6 (2 × CH), 137.8 (C), 146.3 (C), 146.6 (C), 204.1 (C). LRMS 
(70 eV, EI): m/z (%) 377 (M
+
, 28), 334 (34), 296 (100). HRMS calcd for C28H27N, 377.2144; found, 
377.2136. 
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3-(1,1-Dicyclopropylhepta-2,3-dien-1-yl)-1-methyl-1H-indole (1c): Colourless liquid; yield = 65% 
(198 mg); Rf = 0.17 (hexane/AcOEt, 100:1); 
1
H NMR (CDCl3, 300 MHz):  = 0.260.52 (m, 8H), 0.91 
(t, J = 7.4 Hz, 3H), 1.231.49 (m, 4H), 1.912.13 (m, 2H), 3.76 (s, 3H), 5.115.25 (m, 2H), 7.027.10 
(m, 1H), 7.04 (s, 1H), 7.147.23 (m, 1H), 7.247.30 (m, 1H), 7.887.95 (m, 1H). 13C NMR (75.4 MHz, 
CDCl3):  = 1.2 (CH2), 1.3 (CH2), 1.9 (CH2), 2.0 (CH2), 13.8 (CH3), 19.1 (CH), 19.4 (CH), 22.9 (CH2), 
31.4 (CH2), 32.7 (CH3), 42.2 (C), 92.6 (CH), 96.4 (CH), 109.2 (CH), 118.3 (CH), 119.5 (C), 121.0 
(CH), 122.2 (CH), 127.6 (C), 127.7 (CH), 137.4 (C), 204.4 (C). LRMS (70 eV, EI): m/z (%) 305 (M
+
, 
64), 276 (35), 248 (69), 234 (42), 224 (100), 144 (64). HRMS calcd for C22H27N, 305.2144; found, 
305.2143. 
3-(2-Cyclopropylocta-3,4-dien-2-yl)-1-methyl-1H-indole (1d): Yellow liquid; yield = 70% (195 
mg); isolated as a ~1:1 mixture of diastereoisomers; Rf = 0.38 (hexane/diethyl ether, 50:1); 
1
H NMR 
(CDCl3, 300 MHz):  = 0.300.54 (m, 8H), 0.91 (t, J = 7.4 Hz, 6H), 1.27 (m, 6H), 1.42 (s, 3H), 
1.43 (s, 3H), 1.932.09 (m, 4H), 3.74 (s, 6H), 5.155.27 (m, 4H), 6.98 (s, 1 H), 6.99 (s, 1H), 7.017.09 
(m, 2H), 7.157.23 (m, 2H), 7.247.30 (m, 2H), 7.777.87 (m, 2H). 13C NMR (75.4 MHz, CDCl3):  = 
1.39 (CH2), 1.43 (CH2), 1.68 (CH2), 1.74 (CH2), 13.9 (CH3, both isomers), 21.6 (CH, both isomers), 
22.8 (CH2), 22.9 (CH2),  25.6 (CH3), 25.7 (CH3), 31.5 (CH2), 31.6 (CH2), 32.7 (CH3, both isomers), 38.4 
(C, both isomers), 92.98 (CH), 93.0 (CH), 98.0 (CH), 98.3 (CH), 109.3 (CH, both isomers), 118.39 
(CH), 118.43 (CH), 121.2 (CH, both isomers), 121.7 (CH, both isomers), 122.7 (C), 122.8 (C), 125.8 
(CH), 125.9 (CH), 126.9 (C, both isomers), 137.8 (C, both isomers), 203.2 (C, both isomers). LRMS (70 
eV, EI): m/z (%) 279 (M
+
, 32), 222 (28), 198 (100). HRMS calcd for C20H25N, 279.1987; found, 
279.1985. 
1-Methyl-3-(2-methylocta-3,4-dien-2-yl)- 1H-indole (1e): Colourless oil; yield = 69% (175 mg); Rf 
= 0.24 (hexane/diethyl ether, 80:1); 
1
H NMR (CDCl3, 300 MHz):  = 0.93 (t, J = 7.4 Hz, 3H), 1.381.55 
(m, 2H), 1.54 (s, 3H), 1.55 (s, 3H), 1.992.12 (m, 2H), 3.75 (s, 3H), 5.27 (aq, J = 6.6 Hz, 1H), 5.45 (dt, 
J = 6.6, 3.0 Hz, 1H), 6.85 (s, 1H), 7.067.15 (m, 1H), 7.187.26 (m, 1H), 7.277.34 (m, 1H), 7.787.86 
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(m, 1H).
 13
C NMR (100.6 MHz, CDCl3):  13.9 (CH3), 22.8 (CH2), 29.1 (CH3), 29.3 (CH3), 31.5 (CH2), 
32.7 (CH3), 35.3 (C), 93.5 (CH), 102.1 (CH), 109.4 (CH), 118.4 (CH), 121.3 (CH), 121.5 (CH), 123.5 
(C), 124.9 (CH), 126.5 (C), 137.8 (C), 201.7 (C). LRMS (70 eV, EI): m/z (%) 253 (M
+
, 29), 172 (100). 
HRMS calcd for C18H23N, 253.1830; found, 253.1829. 
3-(1-Cyclopropyl-1-phenylpenta-2,3-dien-1-yl)-1-methyl-1H-indole (1f): Colourless oil; yield = 
74% (232 mg); isolated as a ~1:1 mixture of diastereoisomers; Rf = 0.53 (hexane/diethyl ether, 20:1); 
1
H 
NMR (CDCl3, 400 MHz):  = 0.140.36 (m, 4H), 0.470.62 (m, 4H), 1.57 (dd, J = 7.0, 3.2 Hz, 3H), 
1.611.77 (m, 2H), 1.66 (dd, J = 7.0, 3.2 Hz, 3H), 3.80 (s, 3H), 3.81 (s, 3H), 5.065.17 (m, 2H), 5.72 
(td, J = 6.3, 3.1 Hz, 1H), 5.78 (td, J = 6.3, 3.1 Hz, 1H), 6.836.91 (m, 2H), 6.977.05 (m, 2H), 
7.097.34 (m, 12H), 7.347.46 (m, 4H). 13C NMR (75.4 MHz, CDCl3): 1.67 (CH2), 1.74 (CH2), 1.9 
(CH2), 2.0 (CH2), 14.3 (CH3), 14.6 (CH3), 19.9 (CH), 20.5 (CH), 32.8 (CH3, both isomers), 47.9 (C, 
both isomers), 88.0 (CH), 88.1 (CH), 98.0 (CH), 98.2 (CH), 109.1 (CH), 109.2 (CH), 118.46 (CH), 
118.50 (CH), 120.7 (C), 121.1 (C), 121.16 (CH), 121.22 (CH), 121.8 (CH), 122.0 (CH), 126.08 (CH), 
126.13 (CH), 126.7 (C), 127.0 (C), 127.4 (2 × CH), 127.5 (2 × CH), 127.7 (CH), 128.1 (CH), 128.8 (2 × 
CH), 129.1 (2 × CH), 137.66 (C), 137.72 (C), 144.7 (C), 145.4 (C), 204.6 (C), 204.8 (C). LRMS (70 eV, 
EI): m/z (%) 313 (M
+
, 59), 270 (31), 260 (100). HRMS calcd for C23H23N, 313.1830; found, 313.1830. 
3-(1-(4-Chlorophenyl)-1-cyclopropylpenta-2,3-dien-1-yl)-1-methyl-1H-indole (1g): Colourless oil; 
yield = 89% (309 mg); isolated as a ~1:1 mixture of diastereoisomers; Rf = 0.36 (hexane/diethyl ether, 
30:1); 
1
H NMR (CDCl3, 400 MHz):  = 0.130.25 (m, 3H), 0.260.34 (m, 1H), 0.460.62 (m, 4H), 1.55 
(dd, J = 7.0, 3.2 Hz, 3H), 1.591.71 (m, 2H), 1.63 (dd, J = 7.0, 3.2 Hz, 3H), 3.79 (s, 3H), 3.80 (s, 3H), 
5.045.16 (m, 2H), 5.595.65 (m, 1H), 5.665.72 (m, 1H), 6.866.93 (m, 2H), 6.947.04 (m, 2H), 7.12 
(s, 2H), 7.137.23 (m, 6H), 7.267.36 (m, 6H). 13C NMR (75.4 MHz, CDCl3):  = 1.7 (CH2), 1.8 (CH2), 
1.9 (CH2), 2.0 (CH2), 14.2 (CH3), 14.5 (CH3), 20.1 (CH), 20.6 (CH), 32.9 (CH3, both isomers), 47.6 (C, 
both isomers), 88.27 (CH), 88.35 (CH), 97.4 (CH), 97.7 (CH), 109.27 (CH), 109.32 (CH), 118.6 (CH), 
118.7 (CH), 120.3 (C), 120.6 (C), 121.3 (CH), 121.4 (CH), 121.7 (CH), 121.8 (CH), 126.5 (C), 126.8 
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(C), 127.5 (2 × CH), 127.6 (2 × CH), 127.7 (CH), 128.0 (CH), 130.3 (2 × CH), 130.6 (2 × CH), 131.8 
(C), 131.9 (C), 137.7 (C), 137.84(C), 143.5 (C), 144.1 (C), 204.7 (C), 204.9 (C). LRMS (70 eV, EI): m/z 
(%) 349 [(M+2)
+
, 19], 348 [(M+1)
+
, 17], 347 (M
+
, 57), 294 (100). HRMS calcd for C23H22NCl, 
347.1441; found, 347.1455. 
1-Methyl-3-(2-methyl-3-phenylhepta-4,5-dien-3-yl)-1H-indole (1h): Yellow oil; yield = 78% (246 
mg); isolated as a ~1:1 mixture of diastereoisomers; Rf = 0.24 (hexane/diethyl ether, 30:1); 
1
H NMR 
(CDCl3, 300 MHz):  = 0.91 (d, J = 6.7 Hz, 3H), 0.95 (d, J = 6.7 Hz, 3H), 0.98 (d, J = 6.7 Hz, 3H), 1.03 
(d, J = 6.7 Hz, 3H), 1.56 (dd, J = 7.0, 3.3 Hz, 3H), 1.60 (dd, J = 7.0, 3.3 Hz, 3H), 2.762.96 (m, 2H), 
3.79 (s, 3H), 3.79 (s, 3H), 5.015.15 (m, 2H), 5.595.67 (m, 2H), 6.846.92 (m, 2H), 6.987.32 (m, 
14H), 7.377.47 (m, 4H). 13C NMR (75.4 MHz, CDCl3):  = 14.2 (CH3), 14.5 (CH3), 19.19 (CH3), 
19.21 (CH3), 19.4 (CH3), 19.5 (CH3), 32.9 (CH3, both isomers), 34.0 (CH), 34.6 (CH), 52.4 (C), 52.5 
(C), 88.0 (CH), 88.1 (CH), 98.2 (CH), 98.5 (CH), 108.97 (CH), 109.02 (CH), 118.2 (CH), 118.3 (CH), 
119.8 (C), 120.0 (C), 121.08 (CH), 121.09 (CH), 122.6 (CH), 122.9 (CH), 125.75 (CH), 121.79 (CH), 
127.2 (2 × CH), 127.3 (2 × CH + C), 127.5 (C), 127.7 (CH), 127.9 (CH), 129.2 (2 × CH), 129.5 (2 × 
CH), 137.50 (C), 137.51 (C), 143.9 (C), 144.3 (C), 204.0 (C), 204.3 (C). LRMS (70 eV, EI): m/z (%) 
315 (M
+
, 17), 272 (100). HRMS calcd for C23H25N, 315.1987; found, 315.1988. 
3-(1-Cyclopropyl-5-methyl-1-phenylhexa-2,3-dien-1-yl)-1-methyl-1H-indole (1i): Colourless oil; 
yield = 65% (222 mg); isolated as a ~1:1 mixture of diastereoisomers; Rf = 0.41 (hexane/diethyl ether, 
50:1); 
1
H NMR (CDCl3, 300 MHz):  = 0.020.14 (m, 1H), 0.120.33 (m, 3H), 0.400.62 (m, 4H), 0.86 
(dd, J = 6.7, 1.0 Hz, 3H), 0.90 (dd, J = 6.7, 1.0 Hz, 3H), 0.97 (d, J = 6.7 Hz, 6H), 1.661.79 (m, 2H), 
2.122.34 (m, 2H), 3.80 (s, 6H), 5.13 (tdd, J = 6.2, 3.3, 1.0 Hz, 1H), 5.77 (ddd, J = 6.2, 2.9, 1.0 Hz, 1H), 
5.91 (ddd, J = 6.2, 2.9, 1.0 Hz, 1H), 6.806.95 (m, 4H), 7.087.30 (m, 12H), 7.327.44 (m, 4H). 13C 
NMR (75.4 MHz, CDCl3):  = 1.2 (CH2), 1.8 (CH2), 2.0 (CH2), 2.3 (CH2), 19.7 (CH), 20.2 (CH), 22.4 
(2 × CH3), 22.78 (CH3), 22.81 (CH3), 28.47 (CH), 28.51 (CH), 32.9 (CH3, both isomers), 48.0 (C, both 
isomers), 99.9 (CH), 100.3 (CH), 100.9 (CH), 101.1 (CH), 109.1 (CH), 109.2 (CH), 118.46 (CH), 
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118.49 (CH), 120.7 (C), 121.1 (CH), 121.2 (CH), 121.3 (C), 121.7 (CH), 121.9 (CH), 126.07 (CH), 
126.12 (CH), 126.7 (C), 127.0 (C), 127.4 (2 × CH), 127.5 (2 × CH), 127.6 (CH), 128.1 (CH), 128.9 (2 × 
CH), 129.3 (2 × CH), 137.65 (C), 137.71 (C), 144.4 (C), 144.5 (C), 201.9 (C), 202.1 (C). LRMS (70 eV, 
EI): m/z (%) 341 (M
+
, 31), 298 (77), 260 (100). HRMS calcd for C25H27N, 341.2144; found, 341.2146. 
3-(1-Cyclopropyl-1,4-diphenylbuta-2,3-dien-1-yl)-1-methyl-1H-indole (1j): White solid; yield = 
60% (225 mg); isolated as a ~1:1 mixture of diastereoisomers; Rf = 0.22 (hexane/AcOEt, 20:1); 
1
H 
NMR (CDCl3, 300 MHz):  = 0.090.35 (m, 4H), 0.410.52 (m, 1H), 0.520.65 (m, 3H), 1.751.90 (m, 
2H), 3.83 (s, 3H), 3.85 (s, 3H), 6.27 (d, J = 6.3 Hz, 1H), 6.33 (d, J = 6.3 Hz, 1H), 6.37 (d, J = 6.3 Hz, 
1H), 6.43 (d, J = 6.3 Hz, 1H), 6.877.05 (m, 4H), 7.167.40 (m, 22H), 7.417.47 (m, 2H), 7.487.54 
(m, 2H). 
13
C NMR (75.4 MHz, CDCl3):  = 1.6 (CH2), 1.8 (CH2), 1.9 (CH2), 2.0 (CH2), 19.6 (CH), 19.8 
(CH), 32.90 (CH3), 32.93 (CH3), 48.7 (C), 48.8 (C), 97.1 (CH), 97.2 (CH), 103.76 (CH), 103.82 (CH), 
109.3 (CH, both isomers), 118.68 (CH), 118.71 (CH), 120.3 (C), 120.6 (C), 121.3 (CH, both isomers), 
121.6 (CH), 121.7 (CH), 126.36 (CH), 126.39 (CH), 126.68 (C), 126.75 (3 × CH + C), 126.8 (2 × CH), 
127.56 (2 × CH), 127.63 (2 × CH), 128.0 (CH), 128.1 (CH), 128.6 (2 × CH), 128.7 (2 × CH), 129.08 (2 
× CH), 129.13 (2 × CH), 135.07 (C), 135.13 (C), 135.5 (C, both isomers), 137.7 (C), 137.8 (C), 144.1 
(C), 144.2 (C), 205.0 (C), 205.3 (C). ). LRMS (70 eV, EI): m/z (%) 375 (M
+
, 63), 347 (74), 260 (100). 
HRMS calcd for C28H25N, 375.1987; found, 375.1974. 
1-Methyl-3-(1,1,4-triphenylbuta-2,3-dien-1-yl)- 1H-indole (1k): Pale yellow solid; yield = 59% 
(242 mg); Rf = 0.22 (hexane/diethyl ether, 20:1); 
1
H NMR (CDCl3, 400 MHz):  = 3.69 (s, 3H), 6.14 (d, 
J = 6.4 Hz, 1H), 6.44 (s, 1H), 6.68 (d, J = 6.4 Hz, 1H),  6.916.99 (m, 1H), 7.167.41 (m, 18H). 13C 
NMR (75.4 MHz, CDCl3):  = 32.8 (CH3), 54.9 (C), 97.7 (CH), 104.2 (CH), 109.3 (CH), 118.8 (CH), 
121.0 (C), 121.5 (CH), 122.6 (CH), 126.4 (2 × CH), 126.8 (CH), 127.0 (2 × CH), 127.2 (C), 127.7 (2 × 
CH), 127.8 (2 × CH), 128.5 (2 × CH), 129.4 (2 × CH), 129.5 (CH), 129.7 (2 × CH), 134.6 (C), 137.9 
(C), 145.8 (C), 146.3 (C), 205.5 (C). LRMS (70 eV, EI): m/z (%) 411 (M
+
, 78), 296 (100). HRMS calcd 
for C31H25N, 411.1987; found, 411.1986. 
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3-(1-Cyclopropyl-1,4-diphenylpenta-2,3-dien-1-yl)-1-methyl-1H-indole (1l): White foam; yield = 
47% (366 mg); isolated as a ~1:1 mixture of diastereoisomers; Rf = 0.22 (hexane/diethyl ether, 40:1); 
1
H 
NMR (CDCl3, 300 MHz):  = 0.080.31 (m, 4H), 0.390.59 (m, 4H), 1.671.82 (m, 2H), 2.00 (d, J = 
2.9 Hz, 3H), 2.13 (d, J = 2.9 Hz, 3H), 3.79 (s, 3H), 3.83 (s, 3H), 6.136.24 (m, 2H), 6.806.99 (m, 4H), 
7.107.42 (m, 24H), 7.437.49 (m, 2H). 13C NMR (75.4 MHz, CDCl3):  = 1.6 (CH2), 1.7 (CH2), 1.9 
(CH2, both isomers), 17.2 (CH3), 17.3 (CH3), 19.7 (CH), 20.0 (CH), 32.8 (CH3), 32.9 (CH3), 48.8 (C), 
49.0 (C), 101.45 (CH), 101.50 (CH), 102.9 (C), 103.0 (C), 109.2 (CH), 109.3 (CH), 118.5 (CH), 118.6 
(CH), 120.3 (C), 121.16 (C), 121.19 (CH), 121.3 (CH), 121.7 (CH), 121.8 (CH), 125.6 (2 × CH), 125.7 
(2 × CH), 126.2 (CH), 126.3 (CH), 126.4 (CH), 126.5 (CH), 126.7 (C), 126.9 (C), 127.5 (2 × CH), 127.6 
(2 × CH), 127.8 (CH), 128.1 (CH), 128.3 (2 × CH, both isomers), 128.8 (2 × CH), 129.2 (2 × CH), 
137.6 (C, both isomers), 137.7 (C, both isomers), 144.1 (C), 145.2 (C), 204.1 (C), 204.2 (C). LRMS (70 
eV, EI): m/z (%) 389 (M
+
, 62), 260 (100). HRMS calcd for C29H27N, 389.2144; found, 389.2148. 
3-(1-Cyclopropyl-1,4,4-triphenylbuta-2,3-dien-1-yl)-1-methyl-1H-indole (1m): White foam; yield 
= 50% (451 mg); Rf = 0.19 (hexane/diethyl ether, 40:1); 
1
H NMR (CDCl3, 300 MHz):  = 0.070.18 (m, 
1H), 0.190.29 (m, 1H), 0.420.62 (m, 2H), 1.761.88 (m, 1H), 3.79 (s, 3H), 6.39 (s, 1H), 6.736.81 
(m, 1H), 6.836.90 (m, 1H), 7.077.15 (m, 1H), 7.16 (s, 1H), 7.177.46 (m, 16H). 13C NMR (75.4 
MHz, CDCl3):  = 2.0 (CH2), 2.2 (CH2), 20.1 (CH), 32.9 (CH3), 49.2 (C), 102.6 (CH), 109.2 (CH), 
112.0 (C), 118.6 (CH), 120.4 (C), 121.3 (CH), 121.8 (CH), 126.3 (CH), 126.8 (C), 127.0 (CH), 127.1 
(CH), 127.6 (2 × CH), 128.1 (CH), 128.3 (2 × CH), 128.4 (4 × CH), 128.5 (2 × CH), 129.0 (2 × CH), 
137.2 (C), 137.3 (C), 137.7 (C), 144.6 (C), 205.4 (C). LRMS (70 eV, EI): m/z (%) 451 (M
+
, 81), 308 
(51), 260 (100). HRMS calcd for C34H29N, 451.2300; found, 451.2302. 
3-(1-Cyclopropyl-1-phenylbuta-2,3-dien-1-yl)-1-methyl-1H-indole (1n): Colourless oil; yield = 
51% (153 mg); Rf = 0.29 (hexane/AcOEt, 50:1); 
1
H NMR (CDCl3, 300 MHz):  = 0.130.32 (m, 2H), 
0.490.65 (m, 2H), 1.691.82 (m, 1H), 3.82 (s, 3H), 4.714.85 (m, 2H), 5.88 (at, J = 6.6 Hz, 1H), 
6.846.94 (m, 1H), 6.977.02 (m, 1H), 7.147.34 (m, 5H), 7.17 (s, 1H), 7.387.45 (m, 2H). 13C NMR 
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(75.4 MHz, CDCl3):  = 1.8 (CH2), 1.9 (CH2), 20.0 (CH), 32.9 (CH3), 47.5 (C), 77.3 (CH2), 98.4 (CH), 
109.2 (CH), 118.6 (CH), 120.6 (C), 121.3 (CH), 121.7 (CH), 126.3 (CH), 126.8 (C), 127.5 (2 × CH), 
128.0 (CH), 129.0 (2 × CH), 137.7 (C), 144.6 (C), 208.2 (C). LRMS (70 eV, EI): m/z (%) 299 (M
+
, 81), 
284 (54), 270 (88), 260 (100), 144 (48). HRMS calcd for C22H21N, 299.1674; found, 299.1672. 
1-Methyl-3-(2-phenylpenta-3,4-dien-2-yl)-1H-indole (1o): White solid; yield = 52% (142 mg); Rf = 
0.18 (hexane/AcOEt, 50:1); 
1
H NMR (CDCl3, 300 MHz):  = 1.87 (s, 3H), 3.79 (s, 3H), 4.814.93 (m, 
2H), 5.94 (at, J = 6.6 Hz, 1H), 6.98 (s, 1H), 6.967.00 (s, 1H), 7.067.13 (m, 1H), 7.157.34 (m, 5H), 
7.387.44 (m, 2H). 13C NMR (75.4 MHz, CDCl3):  = 28.4 (CH3), 32.9 (CH3), 43.0 (C), 77.8 (CH2), 
100.0 (CH), 109.4 (CH), 118.7 (CH), 121.47 (CH), 121.49 (CH), 122.2 (C), 126.1 (CH), 126.2 (C), 
126.6 (CH),  127.2 (2 × CH), 128.1 (2 × CH), 137.9 (C), 148.2 (C), 207.0 (C). LRMS (70 eV, EI): m/z 
(%) 273 (M
+
, 65), 258 (100), 234 (64). HRMS calcd for C20H19N, 273.1517; found, 273.1516. 
3-(1-Cyclopropyl-1-(thiophen-2-yl)buta-2,3-dien-1-yl)-1-methyl-1H-indole (1p): White solid; 
yield = 75% (229 mg); Rf = 0.18 (hexane/diethyl ether, 30:1); 
1
H NMR (CDCl3, 300 MHz):  = 
0.320.47 (m, 2H), 0.530.65 (m, 2H), 1.741.83 (m, 1H), 3.78 (s, 3H), 4.724.81 (m, 2H), 5.765.83 
(m, 1H), 6.896.93 (m, 2H), 6.946.99 (m, 1H), 7.08 (s, 1H), 7.157.20 (m, 2H), 7.247.31 (m, 2H). 
13
C NMR (75.4 MHz, CDCl3): 2.5 (CH2), 2.6 (CH2), 21.7 (CH), 32.9 (CH3), 45.7 (C), 77.9 (CH2), 
98.3 (CH), 109.3 (CH), 118.8 (CH), 120.1 (C), 121.4 (CH), 121.8 (CH), 123.8 (CH), 125.5 (CH), 126.1 
(CH), 126.9 (C), 127.8 (CH), 137.6 (C), 151.5 (C), 208.1 (C). LRMS (70 eV, EI): m/z (%) 305 (M
+
, 
100), 266 (86). HRMS calcd for C23H15N, 305.1238; found, 305.1233. 
3-(1,1-Diphenylbuta-2,3-dien-1-yl)-1-methyl-1H-indole (1q): Yellow oil; yield = 46% (308 mg); Rf 
= 0.31 (hexane/diethyl ether, 30:1); 
1
H NMR (CDCl3, 300 MHz):  = 3.69 (s, 3H), 4.66 (d, J = 6.6 Hz, 
2H), 6.24 (t, J = 6.6 Hz, 1H),  6.32 (s, 1H), 6.937.02 (m, 1H), 7.167.38 (m, 13H). 13C NMR (75.4 
MHz, CDCl3):  = 32.8 (CH3), 54.0 (C), 78.1 (CH2), 99.5 (CH), 109.2 (CH), 118.7 (CH), 121.0 (C), 
121.4 (CH), 122.7 (CH), 126.4 (2 × CH2), 127.3 (C), 127.7 (4 × CH), 129.5 (4 × CH), 129.6 (CH), 
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137.8 (C), 146.1 (2 × C), 208.5 (C). LRMS (70 eV, EI): m/z (%) 335 (M
+
, 68), 296 (100). HRMS calcd 
for C25H21N, 335.1674; found, 335.1676. 
3-(1,1-Dicyclopropylbuta-2,3-dien-1-yl)-1-methyl-1H-indole (1r): White solid; yield = 60% (158 
mg); M.p. 5658 ºC. 1H NMR (CDCl3, 400 MHz):  = 0.260.33 (m, 2H), 0.360.48 (m, 6H), 
1.231.34 (m, 2H), 3.75 (s, 3H), 4.78 (d, J = 6.7 Hz, 2H), 5.19 (t, J = 6.7 Hz, 1H), 7.02 (s, 1H), 
7.017.07 (m, 1H), 7.147.20 (m, 1H), 7.247.28 (m, 1H), 7.837.87 (m, 1H). 13C NMR (75.4 MHz, 
CDCl3):  = 1.3 (2 × CH2), 2.0 (2 × CH2), 19.3 (2 × CH), 32.8 (CH3), 42.1 (C), 76.5 (CH2), 96.1 (CH), 
109.3 (CH), 118.5 (CH), 119.2 (C), 121.1 (CH), 122.2 (CH), 127.7 (C), 127.8 (CH), 137.4 (C), 208.8 
(C). LRMS (70 eV, EI): m/z (%) 263 (M
+
, 54), 234 (100), 224 (64), 220 (66), 144 (54). HRMS calcd for 
C19H21N, 263.1674; found, 263.1674. 
3-(1-(4-Chlorophenyl)hepta-2,3-dien-1-yl)-1-methyl-1H-indole (1s): Yellow oil; yield = 47% (315 
mg); isolated as a ~1:1 mixture of diastereoisomers; Rf = 0.28 (hexane/diethyl ether, 30:1); 
1
H NMR 
(CDCl3, 300 MHz):  = 0.89 (t, J = 7.3 Hz, 6H), 1.26 (m, 4H), 1.852.08 (m, 4H), 3.77 (s, 3H), 
3.78 (s, 3H), 4.945.02 (m, 2H), 5.125.22 (m, 2H), 5.625.70 (m, 2H), 6.846.89 (m, 2H), 7.037.12 
(m, 2H), 7.217.36 (m, 12H), 7.417.48 (m, 2H). 13C NMR (75.4 MHz, CDCl3):  = 13.68 (CH3), 
13.71 (CH3), 22.48 (CH2), 22.54 (CH2), 31.1 (CH2, both isomers), 32.8 (CH3, both isomers), 42.9 (CH), 
43.0 (CH), 92.9 (CH), 93.0 (CH), 94.5 (CH), 94.6 (CH), 109.3 (CH, both isomers), 117.1 (C), 117.2 (C), 
118.93 (CH), 118.95 (CH), 119.86 (CH), 119.88 (CH), 121.79 (CH), 121.81 (CH), 127.17 (CH), 127.22 
(CH), 128.4 (2 × CH, both isomers), 129.7 (2 × CH, both isomers), 130.0 (C, both isomers), 131.9 (C, 
both isomers), 137.5 (C, both isomers), 142.6 (C, both isomers), 204.17 (C), 204.22 (C). ). LRMS (70 
eV, EI): m/z (%) 337 [(M+2)
+
, 17], 336 [(M+1)
+
, 14], 335 (M
+
, 52), 254 (100). HRMS calcd for 
C22H22NCl, 335.1441; found, 335.1451. 
3-(1-(4-Chlorophenyl)buta-2,3-dien-1-yl)-1-methyl-1H-indole (1t): Yellow oil; yield = 47% (275 
mg); Rf = 0.27 (hexane/diethyl ether, 20:1);. 
1
H NMR (CDCl3, 300 MHz):  = 3.76 (s, 3H), 4.704.78 
(m, 2H), 4.945.00 (m, 1H), 5.595.70 (m, 1H), 6.83 (s, 1H), 7.017.08 (m, 1H), 7.177.34 (m, 6H), 
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7.377.44 (m, 1H). 13C NMR (75.4 MHz, CDCl3):  = 32.8 (CH3), 42.4 (CH), 76.8 (CH2), 94.0 (CH), 
109.4 (CH), 116.8 (C), 119.1 (CH), 119.8 (CH), 121.9 (CH), 127.0 (C), 127.2 (CH), 128.5 (2 × CH), 
129.7 (2 × CH), 132.1 (C), 137.5 (C), 142.2 (C), 208.5 (C). LRMS (70 eV, EI): m/z (%) 295 [(M+2)
+
, 
28], 293 (M
+
, 52), 256 (35), 254 (100). HRMS calcd for C19H16ClN, 293.0971; found, 293.0973. 
1-Methyl-3-(1-(naphthalen-1-yl)buta-2,3-dien-1-yl)-1H-indole (1u): Yellow oil; yield = 48% (297 
mg); Rf = 0.32 (hexane/AcOEtr, 8:1). 
1
H NMR (300 MHz, CD2Cl2):  3.77 (s, 3H), 4.824.91 (m, 2H), 
5.235.33 m, 1H), 5.835.93 m, 1H), 6.89 (bs, 1H), 7.097.19 (m, 1H), 7.237.43 (m, 2H), 7.467.67 
(m, 4H), 7.807.98 (m, 4H). 13C NMR (75.4 MHz, CD2Cl2): 32.7 (CH3), 43.2 (CH), 76.6 (CH2), 94.1 
(CH), 109.3 (CH), 117.3 (C), 119.0 (CH), 120.0 (CH), 121.7 (CH), 125.5 (CH), 125.9 (CH), 126.3 
(CH), 127.1.6 (CH), 127.28 (C), 127.32 (CH), 127.2 (CH), 127.9 (2 × CH), 132.5 (C),133.6 (C), 137.5 
(C), 141.2 (C), 208.6 (C). HRMS calcd for C23H19N, 309.1517; found, 309.1520. 
1-Methyl-3-(4-phenylbuta-2,3-dien-1-yl)-1H-indole (1v): Yellow oil; yield = 46% (238 mg); Rf = 
0.28 (hexane/diethyl ether, 20:1); 
1
H NMR (CDCl3, 300 MHz):  = 3.68 (dd, J = 7.2, 2.6 Hz, 2H), 3.79 
(s, 3H), 5.85 (dt, J = 6.4, 7.2 Hz, 1H), 6.27 (dt, J = 6.4, 2.6 Hz, 1H), 6.98 (s, 1H), 7.147.21 (m, 1H), 
7.227.43 (m, 7H), 7.667.72 (m, 1H). 13C NMR (100.6 MHz, CDCl3):  25.5 (CH2), 32.7 (CH3), 94.6 
(CH), 95.0 (CH), 109.3 (CH), 113.2 (C), 118.9 (CH), 119.3 (CH), 121.8 (CH), 126.6 (CH), 126.86 
(CH), 129.92 (2 × CH), 127.8 (C), 128.7 (2 × CH), 135.0 (C), 137.2 (C), 205.5 (C). LRMS (70 eV, EI): 
m/z (%) 259 (M
+
, 36), 144 (100). HRMS calcd for C19H17N, 259.1361; found, 259.1363. 
Gold(I)-catalyzed synthesis of 4,9-dihydro-1H-carbazoles 2 and 3: 
Method A: A mixture of (PhO)3PAuCl (5 mol%, 14 mg) and AgOTf (5 mol%, 7 mg) in dry toluene 
(0.5 mL) was stirred at room temperature for 5 min and then cooled to –78 ºC. The corresponding 
allenylmethylindole 1 (0.5 mmol) in dry toluene (1 mL) was added and the mixture was stirred allowing 
it to slowly reach rt until complete consumption of starting material (as determined by TLC or GC-MS 
analysis). After filtration through a short pad of celite, using CH2Cl2 as eluent, the solvent was removed 
under reduced pressure and the crude residue purified by flash chromatography on deactivated silica gel, 
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using mixtures of hexane/diethyl ether or hexane/AcOEt as eluent, to afford the corresponding 4,9-
dihydro-1H-carbazoles 2 and/or 3 in the ratio reported in Table 2 and Scheme 3 and yields depicted in 
Table 2 and Schemes 45. The minor regioisomer, if formed in significant amount, was also isolated in 
the yields reported below. Both dihydrocarbazoles were obtained as a ca. 1/1 mixture of diastereomers 
and isolated as variable mixtures of them [notated as maj (major) and min (minor) in the NMR data]. 
Method B: PPh3AuNTf2 (5 mol%, 18 mg) was added to a solution of the corresponding 
allenylmethylindole 1 (0.5 mmol) in dry CH2Cl2 (1.5 mL) at –78 ºC. The resulting mixture was stirred 
allowing it to slowly reach rt until complete consumption of starting material (as determined by TLC or 
GC-MS analysis). After filtration through a short pad of celite, using CH2Cl2 as eluent, the solvent was 
removed under reduced pressure and the crude residue purified by flash chromatography on deactivated 
silica gel, using mixtures of hexane/diethyl ether or hexane/AcOEt as eluent, to afford the corresponding 
4,9-dihydro-1H-carbazoles 2 and/or 3 in the ratio reported in Table 3 and Scheme 3 and yields depicted 
in Table 3 and Schemes 45. The minor regioisomer, if formed in significant amount, was also isolated 
in the yields reported below. Both dihydrocarbazoles were obtained as a ca. 1/1 mixture of 
diastereomers and isolated as variable mixtures of them [notated as maj (major) and min (minor) in the 
NMR data]. 
Spectroscopic and characterization data for 4,9-dihydro-1H-carbazoles 2 and 3: 
4-Cyclopropyl-9-methyl-4-phenyl-1-propyl-4,9-dihydro-1H-carbazole (2a): Colourless oil; yield = 
78% (133 mg) (Method A); isolated as a ~1:2.3 mixture of diastereoisomers; Rf = 0.16 (hexane/AcOEt, 
40:1). 
1
H NMR (300 MHz, CD2Cl2):  = 0.060.29 (m, 3H), 0.390.53 (m, 1H), 0.640.79 (m, 4H), 
0.94 (t, J = 7.3 Hz, 3H, maj), 1.05 (t, J = 7.1 Hz, 3H, min), 1.261.98 (m, 10H), 3.583.69 (m, 2H, both 
isomers), 3.74 (s, 3H, min), 3.77 (s, 3H, may), 5.49 (dd, J = 10.1, 2.0 Hz, 1H, maj), 5.52 (dd, J = 10.0, 
1.4 Hz, 1H, min), 5.88 (dd, J = 10.1, 3.6 Hz, 1H, maj), 6.04 (dd, J = 10.0, 4.2 Hz, 1H, min), 6.756.82 
(m, 1H, min), 6.836.90 (m, 1H, maj), 6.93m, 1H, min7.36 (m, 11H), 7.497.65 (m, 
4H).
 13
C NMR (75.4 MHz, CD2Cl2): = 1.0 (CH2, maj), 2.5 (CH2, min), 2.6 (CH2, min), 3.0 (CH2, maj), 
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14.1 (CH3, both isomers), 19.2 (CH, maj), 19.4 (CH2, min), 20.2 (CH, min), 20.8 (CH2, maj), 30.1 (CH3, 
min), 30.5 (CH3, maj), 33.26 (CH, maj), 33.34 (CH, min), 38.1 (CH2, maj), 39.9 (CH2, min), 45.8 (C, 
maj), 46.3 (C, min), 108.78 (CH, min), 108.82 (CH, maj), 113.0 (C, min), 114.2 (C, maj), 118.5 (CH, 
both isomers), 119.8 (CH, min), 120.0 (CH, maj), 120.5 (CH, min), 120.6 (CH, maj), 125.4 (C, maj), 
125.6 (C, min), 125.76 (CH, min), 125.84 (CH, maj), 126.3 (CH, min) 127.5 (CH, maj), 127.80 (2 × 
CH, min), 127.83 (2 × CH, maj), 127.99 (2 × CH, maj), 128.04 (2 × CH, min), 130.5 (CH, maj), 132.4 
(CH, min), 136.6 (C, both isomers), 137.6 (C, min), 137.8 (C, maj), 148.4 (C, maj), 148.8 (C, min). 
LRMS (70 eV, EI): isomer 1: m/z (%) 341 (M
+
, 67), 300 (100), 257 (93); isomer 2: m/z (%) 341 (M
+
, 
78), 300 (72), 270 (100), 257 (94). HRMS calcd for C25H27N, 341.2144; found, 341.2143. 
1-Cyclopropyl-9-methyl-1-phenyl-4-propyl-4,9-dihydro-1H-carbazole (3a): Colourless oil; yield = 
68% (116 mg) (Method B); isolated as a ~1:1.3 mixture of diastereoisomers; Rf = 0.25 (hexane/AcOEt, 
40:1). 
1
H NMR (400 MHz, CD2Cl2):  = 0.070.15 (m, 1H), 0.280.38 (m, 2H), 0.400.50 (m, 1H), 
0.750.89 (m, 4H), 0.96 (t, J = 7.3 Hz, 3H, maj), 1.05 (t, J = 7.3 Hz, 3H, min), 1.301.44 (m, 2H), 
1.501.82 (m, 5H), 1.922.12 (m, 2H), 2.152.27 (m, 1H), 3.32 (s, 3H, min), 3.36 (s, 3H, maj), 
3.753.85 (m, 2H, both isomers), 5.285.31 (m, 1H, maj), 5.315.33 (m, 1H, min), 5.90 (dd, J = 10.0, 
3.0 Hz, 1H, maj), 6.02 (dd, J = 10.0, 3.9 Hz, 1H, min), 7.147.40 (m, 14H, both isomers), 7.487.53 (m, 
2H, both isomers), 7.707.77 (m, 2H, both isomers). 13C NMR (75.4 MHz, CD2Cl2):  = 0.9 (CH2, maj), 
1.5 (CH2, min), 3.1 (CH2, min), 3.2 (CH2, maj), 14.6 (CH3, both isomers), 18.6 (CH, min), 19.1 (CH2, 
maj), 19.4 (CH, maj), 20.3 (CH2, min), 31.4 (CH3, min), 31.5(CH3, maj), 34.3 (CH, maj), 34.5 (CH, 
min), 37.8 (CH2, maj), 39.8 (CH2, min), 45.4 (C, maj), 45.6 (C, min), 108.9 (CH, both isomers), 111.5 
(C, maj), 112.2 (C, min), 118.7 (CH, maj), 118.8 (CH, min), 119.1 (CH, min), 119.4 (CH, maj), 121.0 
(CH, maj), 121.1 (CH, min), 125.8 (C, min), 125.9 (C, maj), 126.42 (CH, min), 126.45 (CH, maj), 127.5 
(2 × CH, maj), 127.6 (2 × CH, min), 128.6 (2 × CH, min), 128.7 (2 × CH, maj), 128.9 (CH, maj), 129.0 
(CH, min), 129.2 (CH, min), 129.6 (CH, maj), 137.7 (C, min), 137.8 (C, maj), 138.4 (C, min), 138.7 (C, 
maj), 147.4 (C, min), 147.5 (C, maj). LRMS (70 eV, EI): isomer 1: m/z (%) 341 (M
+
, 16), 298 (100), 
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257 (48); isomer 2: m/z (%) 341 (M
+
, 17), 298 (100), 257 (49). ). HRMS calcd for C25H27N, 341.2144; 
found, 341.2162. 
9-Methyl-4,4-diphenyl-1-propyl-4,9-dihydro-1H-carbazole (2b): White solid; yield = 91% (171 
mg) (Method A); M.p. = 171173 ºC. 1H NMR (400 MHz, CD2Cl2):  = 0.88 (t, J = 7.3 Hz, 3H), 
1.191.35 (m, 2H), 1.581.73 (m, 1H), 1.771.92 (m, 1H), 3.83 (m, 1H), 3.78 (s, 3H),6.06 (dd, J 
= 9.9, 4.2 Hz, 1H), 6.26 (dd, J = 9.8, 1.5 Hz, 1H), 6.776.86 (m, 1H), 6.997.39 (m, 13H). 13C NMR 
(100.6 MHz, CD2Cl2): 14.0 (CH3), 19.3 (CH2), 30.1 (CH3), 33.3 (CH), 37.8 (CH2), 52.4 (C), 108.8 
(CH), 113.0 (C), 118.7 (CH), 120.4 (CH), 120.7 (CH), 125.1 (CH), 125.8 (CH), 126.0 (CH), 126.1 (C), 
127.6 (2 × CH), 127.9 (2 × CH), 129.0 (2 × CH), 129.1 (2 × CH), 136.6 (CH), 137.3 (C), 137.7 (C), 
145.9 (C), 147.7 (C). LRMS (70 eV, EI): m/z (%) 377 (M
+
, 49), 335 (28), 334 (100), 300 (37), 257 (33). 
LRMS (70 eV, EI): m/z (%) 377 (M
+
, 49), 334 (100), 300 (37), 257 (33). HRMS calcd for C28H27N, 
377.2144; found, 377.2152. 
9-methyl-1,1-diphenyl-4-propyl-4,9-dihydro-1H-carbazole (3b): White solid; yield = 20% (38 mg) 
(Method B); M.p. = 160162 ºC. 1H NMR (400 MHz, CD2Cl2):  = 0.87 (t, J = 7.4 Hz, 3H), 1.201.32 
(m, 2H), 1.751.87 (m, 1H), 1.912.02 (m, 1H), 3.12 (s, 3H), 3.93 (m, 1H), 5.96 (dd, J = 9.8, 3.6 
Hz, 1H), 6.04 (dd, J = 9.8, 1.4 Hz, 1H), 7.077.13 (m, 1H), 7.147.39 (m, 12H), 7.677.73 (m, 1H). 13C 
NMR (100.6 MHz, CD2Cl2): 14.2 (CH3), 19.4 (CH2), 31.7 (CH3), 34.2 (CH), 38.1 (CH2), 51.8 (C), 
108.9 (CH), 112.4 (C), 118.8 (CH), 119.2 (CH), 121.3 (CH), 125.7 (C), 126.0 (CH), 126.4 (CH), 126.5 
(CH), 128.1 (2 × CH), 128.3 (2 × CH), 129.1 (2 × CH), 129.3 (2 × CH), 135.2 (CH), 137.1 (C), 137.6 
(C), 143.7 (C), 144,7 (C). LRMS (70 eV, EI): m/z (%) 377 (M
+
, 44), 335 (81), 334 (100), 319 (32), 257 
(39). HRMS calcd for C28H27N, 377.2144; found, 377.2138. 
4,4-Dicyclopropyl-9-methyl-1-propyl-4,9-dihydro-1H-carbazole (2c): White solid; yield = 57% 
(87 mg) (Method A); M.p. = 101103 ºC. 1H NMR (400 MHz, CD2Cl2):  = 0.180.45 (m, 6H), 
0.480.56 (m, 1H), 0.710.80 (m, 1H), 0.95 (t, J = 7.3 Hz, 3H), 1.231.32 (m, 1H), 1.341.61 (m, 4H), 
1.821.93 (m, 1H),3.52 (m, 1H), 3.69 (s, 3H), 5.46 (dd, J = 10.2, 1.6 Hz, 1H), 5.94 (dd, J = 10.2, 
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4.0 Hz, 1H), 7.017.08 (m, 1H), 7.117.17 (m, 1H), 7.277.32 (m, 1H), 7.847.89 (m, 1H). 13C NMR 
(100.6 MHz, CD2Cl2):  = 0.6 (CH2), 1.3 (CH2), 1.5 (CH2), 2.2 (CH2), 14.1 (CH3), 19.3 (CH), 19.6 
(CH2), 20.5 (CH), 30.1 (CH3), 33.5 (CH), 39.2 (CH2), 40.4 (C), 108.9 (CH), 114.1 (C), 118.5 (CH), 
120.4 (CH), 121.0 (CH), 126.1 (C), 127.7 (CH), 130.1 (CH), 136.6 (C), 137.6 (C). LRMS (70 eV, EI): 
m/z (%) 305 (M
+
, 28), 264 (100), 221 (28). HRMS calcd for C22H27N, 305.2144; found, 305.2138. 
4-Cyclopropyl-4,9-dimethyl-1-propyl-4,9-dihydro-1H-carbazole (2d): Colourless oil; yield = 64% 
(89 mg) (Method A); isolated as a ~1:1 mixture of diastereoisomers; Rf = 0.26 (hexane/diethyl ether, 
100:1). 
1
H NMR (400 MHz, CD2Cl2):  = 0.150.35 (m, 4H), 0.380.55 (m, 3H), 0.590.68 (m, 1H), 
0.88 (t, J = 7.3 Hz, 3H), 0.97 (t, 7.2 Hz, 3H), 1.021.17 (m, 1H), 1.271.62 (m, 6H), 1.41 (s, 3H), 1.48 
(s, 3H), 1.631.82 (m, 2H), 1.831.93 (m, 1H), 3.483.54 (m, 1H), 3.593.64 (m, 1H), 3.69 (s, 3H), 
3.70 (s, 3H), 5.555.60 (m, 2H), 5.80 (dd, J = 10.1, 3.9 Hz, 1H), 5.90 (dd, J = 10.1, 4.2 Hz, 1H), 
7.037.08 (m, 2H), 7.127.18 (m, 2H), 7.287.33 (m, 2H), 7.727.80 (m, 2H). 13C NMR (100.6 MHz, 
CDCl3):  = 1.2 (CH2), 1.5 (CH2), 1.8 (CH2), 1.9 (CH2), 14.05 (CH3), 14.08 (CH3), 18.5 (CH2), 19.6 
(CH2), 21.9 (CH), 22.1 (CH), 25.9 (CH3), 26.6 (CH3), 29.9 (CH3), 30.2 (CH3), 33.5 (2 × CH), 36.8 (C), 
37.5 (CH2), 37.6 (C), 39.4 (CH2), 108.86 (CH), 108.94 (CH), 114.6 (C), 116.2 (C), 118.4 (CH), 118.5 
(CH), 120.3 (CH), 120.4 (3 × CH), 125.6 (C), 125.7 (C), 125.9 (CH), 126.3 (CH), 133.7 (CH), 134.6 
(CH), 135.4 (C), 136.4 (C), 137.6 (C), 137.7 (C). LRMS (70 eV, EI): m/z (%) 279 (M
+
, 58), 264 (100), 
238 (73), 195 (81). HRMS calcd for C20H25N, 279.1987; found, 279.1996. 
4,4,9-Trimethyl-1-propyl-4,9-dihydro-1H-carbazole (2e): Colourless oil; yield = 80% (101 mg) 
(Method A); Rf = 0.25 (hexane/diethyl ether, 100:1). 
1
H NMR (400 MHz, CD2Cl2):  = 0.88 (t, J = 7.4 
Hz, 3H), 1.051.21 (m, 1H), 1.271.43 (m, 1H), 1.49 (s, 3H), 1.50 (s, 3H), 1.631.82 (m, 
2H),3.64 (m, 1H), 3.69 (s, 3H), 5.715.79 (m, 2H), 7.027.08 (m, 1H), 7.117.17 (m, 1H), 
7.287.32 (m, 1H), 7.657.70 (m, 1H). 13C NMR (75.4 MHz, CD2Cl2): 14.1 (CH3), 18.6 (CH2), 29.8 
(CH3), 29.9 (CH3), 30.0 (CH3), 35.5 (CH), 34.7 (C), 37.7 (CH2), 109.0 (CH), 116.0 (C), 118.4 (CH), 
119.8 (CH), 120.4 (CH), 124.2 (CH), 125.4 (C), 135.2 (C), 137.7 (C), 138.6 (CH). LRMS (70 eV, EI): 
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m/z (%) 253 (M
+
, 21), 252 (76), 236 (53), 210 (100). HRMS calcd for C18H23N, 253.1830; found, 
253.1832. 
4-Cyclopropyl-1,9-dimethyl-4-phenyl-4,9-dihydro-1H-carbazole (2f): Colourless oil; yield = 57% 
(89 mg) (Method A); isolated as a ~1:1.4 mixture of diastereoisomers; Rf = 0.28 (hexane/diethyl ether, 
100:1). 
1
H NMR (400 MHz, CD2Cl2):  = 0.160.84 (m, 2H), 0.360.53 (m, 2H), 0.640.81 (m, 3H, 
both isomers), 0.880.97 (m, 1H, min), 1.48 (d, J = 6.9 Hz, 3H, maj), 1.50 (d, J = 7.0 Hz, 3H, min), 
1.801.90 (m, 1H, min), 1.942.05 (m, 1H, maj), 3.623.74 (m, 2H, both isomers), 3.76 (s, 3H, min), 
3.78 (s, 3H, maj), 5.45 (dd, J = 10.0, 1.9 Hz, 1H, maj), 5.52 (dd, J = 9.9, 1.4 Hz, 1H, min), 5.85 (dd, J = 
10.0, 3.7 Hz, 1H, maj), 5.92 (dd, J = 9.9, 4.2 Hz, 1H, min), 6.796.86 (m, 1H, min), 6.866.92 (m, 1H, 
maj), 6.967.01 (m, 1H, min), 7.067.25 (m, 6H, both isomers), 7.267.36 (m, 5H, both isomers), 
7.557.65 (m, 4H, both isomers). 13C NMR (75.4 MHz, CD2Cl2):  = 1.2 (CH2, maj), 2.5 (CH2, min), 
2.7 (CH2, min), 2.9 (CH2, maj), 19.5 (CH, min), 20.3 (CH, maj), 22.4 (CH3, maj), 22.8 (CH3, min), 28.5 
(CH, maj), 28.6 (CH, min), 30.0 (CH3, min), 30.4 (CH3, maj), 46.0 (C, maj), 46.4 (C, min), 108.8 (CH, 
min), 108.9 (CH, maj), 112.5 (C, min), 113.2 (C, maj), 118.5 (CH, min), 118.6 (CH, maj), 120.0 (CH, 
min), 120.1 (CH, maj), 120.6 (CH, min), 120.7 (CH, maj), 125.4 (C, maj), 125.7 (C, min), 125.8 (CH, 
min), 125.9 (CH, maj), 127.87 (2 × CH, maj), 127.88 (2 × CH, min), 128.06 (2 × CH, maj), 128.10 (2 × 
CH, min), 128.4 (CH, min), 129.2 (CH, maj), 129.6 (CH, maj), 131.7 (CH, min), 137.6 (C, min), 137.78 
(C, maj), 137.84 (C, maj), 138.2 (C, min), 148.4 (C, maj), 148.7 (C, min). LRMS (70 eV, EI): m/z (%) 
313 (M
+
, 58), 272 (100), 257 (47). HRMS calcd for C23H23N, 313.1830; found, 313.1836. 
1-Cyclopropyl-4,9-dimethyl-1-phenyl-4,9-dihydro-1H-carbazole (3f): Colourless oil; yield = 15% 
(24 mg) (Method A), 24% (38 mg) (Method B) ; isolated as a ~1:1.1 mixture of diastereoisomers; Rf = 
0.21 (hexane/diethyl ether, 200:1). 
1
H NMR (400 MHz, CD2Cl2):  = 0.050.14 (m, 1H, maj), 
0.190.28 (m, 1H, min), 0.290.37 (m, 1H, maj), 0.370.47 (m, 1H, min), 0.740.93 (m, 4H, both 
isomers), 1.48 (d, J = 7.1 Hz, 3H, min), 1.50 (d, J = 7.1 Hz, 3H, maj), 1.701.80 (m, 2H, both isomers), 
3.27 (s, 3H, min), 3.31 (s, 3H, maj), 3.693.84 (m, 2H, both isomers), 5.22 (dd, J = 9.9, 1.6 Hz, 1H, 
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min), 5.23 (dd, J = 10.0, 2.1 Hz, 1H, maj), 5.83 (dd, J = 10.0, 3.1 Hz, 1H, maj), 5.89 (dd, J = 9.9, 3.9 
Hz, 1H, min), 7.077.13 (m, 2H), 7.157.20 (m, 2H), 7.207.36 (m, 8H, both isomers), 7.367.42 (m, 
2H), 7.427.48 (m, 2H), 7.617.70 (m, 2H). 13C NMR (75.4 MHz, CD2Cl2):  = 0.5 (CH2, maj), 1.0 
(CH2, min), 2.9 (CH2, both isomers), 18.4 (CH, min), 19.0 (CH, maj), 22.5 (CH3, maj), 23.0 (CH3, min), 
29.4 (CH, maj), 29.5 (CH, min), 31.2 (CH3, min), 31.3 (CH3, maj), 45.4 (C, maj), 45.5 (C, min), 108.8 
(CH, both isomers), 112.86 (C, maj), 112.94 (C, min), 118.65 (CH, min), 118.70 (CH, maj), 118.8 (CH, 
min), 119.2 (CH, maj), 121.0 (CH, both isomers), 125.8 (C, both isomers), 126.3 (CH, both isomers), 
127.50 (2 × CH, min), 127.53 (2 × CH, maj), 127.8 (CH, maj), 128.2 (CH, min), 128.5 (2 × CH, min), 
128.6 (2 × CH, maj), 131.0 (CH, min), 131.2 (CH, maj), 137.6 (C, maj), 137.7 (C, min), 137.8 (C, maj), 
137.9 (C, min), 147.2 (C, maj), 147.3 (C, min). LRMS (70 eV, EI): m/z (%) 313 (M
+
, 80), 298 (100), 
257 (61). HRMS calcd for C23H23N, 313.1830; found, 313.1829. 
4-(4-Chlorophenyl)-4-cyclopropyl-1,9-dimethyl-4,9-dihydro-1H-carbazole (2g): White solid; 
yield = 66% (115 mg) (Method A); isolated as a ~1:1 mixture of diastereoisomers; Rf = 0.20 
(hexane/diethyl ether, 100:1). 
1
H NMR (300 MHz, CD2Cl2):  = 0.100.34 (m, 2H), 0.350.54 (m, 2H), 
0.600.82 (m, 3H), 0.830.99 (m, 1H), 1.46 (d, J = 6.9 Hz, 3H), 1.48 (d, J = 7.0 Hz, 3H), 1.731.86 (m, 
1H), 1.871.99 (m, 1H), 3.603.75 (m, 2H), 3.76 (s, 3H), 3.78 (s, 3H), 5.39 (dd, J = 10.0, 1.9 Hz, 1H), 
5.46 (dd, J = 9.9, 1.4 Hz, 1H), 5.85 (dd, J = 10.0, 3.7 Hz, 1H), 5.92 (dd, J = 9.9, 4.3 Hz, 1H), 6.806.86 
(m, 1H), 6.876.93 (m, 1H), 6.946.98 (m, 1H), 7.057.17 (m, 3H), 7.227.36 (m, 6H), 7.477.60 (m, 
4H).
 13
C NMR (100.6 MHz, CD2Cl2): 1.3 (CH2), 2.5 (CH2), 2.7 (CH2), 2.8 (CH2), 19.5 (CH), 20.3 
(CH), 22.4 (CH3), 22.7 (CH3), 28.5 (CH), 28.6 (CH), 30.0 (CH3), 30.4 (CH3), 45.7 (C), 46.1 (C), 108.87 
(CH), 108.92 (CH), 112.0 (C), 112.8 (C), 118.7 (CH, both isomers), 119.9 (CH), 120.0 (CH), 120.7 
(CH), 120.8 (CH), 125.2 (C), 125.4 (C), 127.9 (2 × CH), 128.1 (2 × CH), 128.8 (CH), 129.1 (CH), 129.4 
(2 × CH), 129.6 (2 × CH), 129.7 (CH), 131.2 (CH), 131.4 (C), 131.5 (C), 137.6 (C), 137.8 (C), 137.9 
(C), 138.3 (C), 147.2 (C), 147.4 (C). LRMS (70 eV, EI): m/z (%) 349 [(M+2)
+
, 21], 348 [(M+1)
+
, 16], 
347 (M
+
, 61), 306 (100). HRMS calcd for C23H22NCl, 347.1441; found, 347.1437. 
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1-(4-Chlorophenyl)-1-cyclopropyl-4,9-dimethyl-4,9-dihydro-1H-carbazole (3g): Colourless oil; 
yield = 11% (19 mg) (Method A), 28% (49 mg) (Method B); isolated as a ~1:1.7 mixture of 
diastereoisomers; Rf = 0.21 (hexane/diethyl ether, 200:1). 
1
H NMR (400 MHz, CD2Cl2):  = 0.040.13 
(m, 1H, maj), 0.190.26 (m, 1H, min), 0.280.37 (m, 1H, maj), 0.380.46 (m, 1H, min), 0.730.92 (m, 
4H, both isomers), 1.47 (d, J = 7.0 Hz, 3H), 1.49 (d, J = 7.1 Hz, 3H), 1.661.76 (m, 1H, maj), 1.791.86 
(m, 1H, min), 3.28 (s, 3H, min), 3.32 (s, 3H, maj), 3.673.81 (m, 2H, both isomers), 5.17 (dd, J = 9.9, 
1.6 Hz, 1H, min), 5.18 (dd, J = 10.0, 2.1 Hz, 1H, maj), 5.84 (dd, J = 10.0, 3.1 Hz, 1H, maj), 5.90 (dd, J 
= 9.9, 3.9 Hz, 1H, min), 7.067.13 (m, 2H, both isomers), 7.147.21 (m, 2H, both isomers), 7.237.44 
(m, 10H, both isomers), 7.617.67 (m, 2H, both isomers). 13C NMR (75.4 MHz, CD2Cl2):  = 0.4 
(CH2, maj), 0.1 (CH2, min), 1.9 (CH2, both isomers), 17.3 (CH, min), 17.9 (CH, maj), 21.5 (CH3, maj), 
21.9 (CH3, min), 28.4 (CH, maj), 28.5 (CH, min), 30.3 (CH3, min), 30.4 (CH3, maj), 44.1 (C, maj), 44.2 
(C, min), 107.9 (CH, both isomers), 112.0 (C, maj), 112.1 (C, min), 117.78 (CH, maj), 117.83 (CH, 
min), 117.9 (CH, min), 118.3 (CH, maj), 120.2 (CH, both isomers), 124.7 (C, both isomers), 126.3 (CH, 
maj), 126.7 (CH, min), 127.58 (2 × CH, min), 127.64 (2 × CH, maj), 128.1 (2 × CH, both isomers), 
130.4 (CH, min), 130.7 (CH, maj), 131.0 (C, both isomers), 136.2 (C, maj), 136.3 (C, min), 136.7 (C, 
min), 136.9 (C, maj), 145.0 (C, maj), 145.1 (C, min). LRMS (70 eV, EI): m/z (%) 349 [(M+2)
+
, 27], 348 
[(M+1)
+
, 19], 347 (M
+
, 72), 332 (100). HRMS calcd for C23H22NCl, 347.1441; found, 347.1428. 
4-Isopropyl-1,9-dimethyl-4-phenyl-4,9-dihydro-1H-carbazole (2h): White solid; yield = 76% (120 
mg) (Method A); Both diastereoisomers (A and B) were isolated separately. 
Isomer A: White solid; M.p. 126128 ºC. 1H NMR (300 MHz, CD2Cl2):  = 0.65 (d, J = 6.7 Hz, 3H), 
1.07 (d, J = 6.7 Hz, 3H), 1.47 (d, J = 6.9 Hz, 3H), 3.32 (sept, J = 6.7, 1H), 3.603.72 (m, 1H), 3.70 (s, 
3H), 5.87 (dd, J = 10.1, 1.7 Hz, 1H), 6.17 (dd, J = 10.1, 3.9 Hz, 1H), 6.896.97 (m, 1H), 7.047.16 (m, 
2H), 7.227.34 (m, 3H), 7.557.67 (m, 3H). 13C NMR (75.4 MHz, CD2Cl2):  = 17.8 (CH3), 18.7 
(CH3), 22.0 (CH3), 28.7 (CH), 30.1 (CH3), 31.9 (CH), 50.7 (C), 108.8 (CH), 113.6 (C), 118.5 (CH), 
120.1 (CH), 120.5 (CH), 125.0 (C), 125.5 (CH), 127.9 (2 × CH), 128.2 (2 × CH), 129.2 (CH), 130.6 
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(CH), 137.5 (C), 137.6 (C), 146.4 (C). LRMS (70 eV, EI): m/z (%) 315 (M
+
, 3), 273 (24), 272 (100), 
257 (34). LRMS (70 eV, EI): m/z (%) 315 (M
+
, 2), 273 (24), 272 (100), 257 (34). HRMS calcd for 
C23H25N, 315.1987; found, 315.1982. 
Isomer B: White solid; M.p. 153155 ºC. 1H NMR (300 MHz, CD2Cl2):  = 0.81 (d, J = 6.7 Hz, 3H), 
1.14 (d, J = 6.7 Hz, 3H), 1.47 (d, J = 6.9 Hz, 3H), 3.32 (sept, J = 6.7, 1H), 3.673.78 (m, 1H), 3.72 (s, 
3H), 5.76 (dd, J = 10.1, 1.6 Hz, 1H), 6.10 (dd, J = 10.1, 4.1 Hz, 1H), 6.816.89 (m, 1H), 7.027.15 (m, 
2H), 7.227.35 (m, 4H), 7.477.54 (m, 2H). 13C NMR (75.4 MHz, CD2Cl2):  = 18.4 (CH3), 19.8 
(CH3), 21.7 (CH3), 28.6 (CH), 30.1 (CH3), 31.0 (CH), 50.7 (C), 108.6 (CH), 113.2 (C), 118.3 (CH), 
120.1 (CH), 120.5 (CH), 125.1 (C), 125.4 (CH), 127.7 (2 × CH), 128.5 (2 × CH), 129.5 (CH), 130.4 
(CH), 137.4 (C), 137.6 (C), 146.3 (C). LRMS (70 eV, EI): m/z (%) 315 (M
+
, 5), 273 (33), 272 (100), 
257 (50). LRMS (70 eV, EI): m/z (%) 315 (M
+
, 5), 273 (33), 272 (100), 257 (50). HRMS calcd for 
C23H25N, 315.1987; found, 315.1988. 
1-Isopropyl-4,9-dimethyl-1-phenyl-4,9-dihydro-1H-carbazole (3h): White solid; yield = 8% (13 
mg) (Method A); isolated as a ~1:10 mixture of diastereoisomers, the data of the major diastereoisomer 
are reported; M.p. 120122 ºC. 1H NMR (400 MHz, CD2Cl2):  = 0.56 (d, J = 6.7 Hz, 3H), 1.22 (d, J = 
6.7 Hz, 3H), 1.60 (d, J = 7.1 Hz, 3H), 3.10 (sept, J = 6.7, 1H), 3.27 (s, 3H), 3.723.81 (m, 1H), 5.61 (dd, 
J = 10.1, 2.2 Hz, 1H), 6.05 (dd, J = 10.1, 3.1 Hz, 1H), 7.027.08 (m, 1H), 7.097.14 (m, 1H), 7.157.22 
(m, 2H), 7.267.34 (m, 2H), 7.427.50 (m, 2H), 7.617.67 (m, 1H). 13C NMR (75.4 MHz, CD2Cl2):  = 
18.69 (CH3), 18.74 (CH3), 22.6 (CH3), 29.5 (CH), 30.9 (CH3), 31.7 (CH), 49.3 (C), 108.7 (CH), 113.0 
(C), 118.6 (CH), 119.1 (CH), 120.8 (CH), 125.6 (C), 126.1 (CH), 127.8 (CH), 128.1 (2 × CH), 129.2 (2 
× CH), 131.4 (CH), 137.5 (C), 138.0 (C), 144.4 (C). LRMS (70 eV, EI): m/z (%) 315 (M
+
, 10), 273 (23), 
272 (100), 257 (30). HRMS calcd for C23H25N, 315.1987; found, 315.1985. 
4-Cyclopropyl-1-isopropyl-9-methyl-4-phenyl-4,9-dihydro-1H-carbazole (2i): Colourless oil; 
yield = 70% (119 mg) (Method A); isolated as a ~1:1.2 mixture of diastereoisomers; Rf = 0.20 
(hexane/diethyl ether, 100:1). 
1
H NMR (400 MHz, CD2Cl2):  = 0.000.11 (m, 1H), 0.110.22 (m, 1H), 
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0.410.67 (m, 2H), 0.60 (d, J = 6.9 Hz, 3H), 0.670.86 (m, 3H), 0.81 (d, J = 6.8 Hz, 3H), 0.850.95 (m, 
1H), 1.19 (d, J = 7.0 Hz, 3H, min), 0.60 (d, J = 6.9 Hz, 3H, maj), 1.801.90 (m, 1H, min), 1.932.05 
(m, 1H, maj), 2.392.54 (m, 2H), 3.573.63 (m, 1H), 3.673.71 (m, 1H), 3.75 (s, 3H, maj), 3.76 (s, 3H, 
min), 5.58 (dd, J = 10.2, 1.7 Hz, 1H, maj), 5.66 (dd, J = 10.3, 2.0 Hz, 1H, min), 5.87 (dd, J = 10.3, 3.5 
Hz, 1H, min), 5.92 (dd, J = 10.2, 3.8 Hz, 1H, maj), 6.796.86 (m, 1H), 6.866.92 (m, 1H), 7.037.16 
(m, 5H), 7.167.36 (m, 7H), 7.497.55 (m, 2H), 7.587.63 (m, 2H). 13C NMR (100.6 MHz, CD2Cl2):  
= 0.9 (CH2), 2.5 (CH2), 2.6 (CH2), 3.3 (CH2), 17.1 (CH3), 18.0 (CH3), 19.4 (CH), 20.7 (CH3), 20.9 
(CH3), 21.9 (CH), 30.9 (CH3, both isomers), 31.5 (CH, both isomers), 39.4 (CH), 40.0 (CH), 45.9 (C), 
46.2 (C), 108.9 (CH, both isomers), 114.8 (C), 115.1 (C), 118.5 (CH), 118.6 (CH), 119.9 (CH), 120.4 
(CH), 120.7 (CH, both isomers), 122.7 (CH), 123.0 (CH), 125.6 (C, both isomers), 125.7 (CH), 125.9 
(CH), 127.8 (2 × CH), 127.95 (2 × CH), 127.97 (2 × CH), 128.02 (2 × CH), 132.7 (CH), 133.4 (CH), 
136.3 (C), 136.5 (C), 138.1 (C), 138.2 (C), 148.4 (C), 149.0 (C). LRMS (70 eV, EI): m/z (%) 341 (M
+
, 
21), 298 (100), 257 (47). HRMS calcd for C25H27N, 341.2144; found, 341.2145. 
1-Cyclopropyl-4-isopropyl-9-methyl-1-phenyl-4,9-dihydro-1H-carbazole (3i): White solid; yield = 
72% (123 mg) (Method B); isolated as a ~1:1.4 mixture of diastereoisomers; Rf = 0.32 (hexane/diethyl 
ether, 100:1). 
1
H NMR (400 MHz, CD2Cl2):  = 0.040.05 (m, 1H), 0.220.32 (m, 1H), 0.390.47 (m, 
2H??), 0.62 (d, J = 6.8 Hz, 3H, maj), 0.70 (d, J = 6.8 Hz, 3H, min), 0.730.90 (m, 4H), 1.21 (d, J = 7.0 
Hz, 3H, maj), 1.25 (d, J = 7.0 Hz, 3H, min), 1.641.79 (m, 1H, maj), 1.781.87 (m, 1H, min), 2.681.89 
(m, 2H, both isomers), 3.33 (s, 3H, maj), 3.34 (s, 3H, min), 3.693.74 (m, 1H, maj), 3.773.80 (m, 1H, 
min),5.36 (dd, J = 10.2, 2.3 Hz, 1H, maj), 5.38 (dd, J = 10.2, 1.9 Hz, 1H, min), 5.865.93 (m, 2H, both 
isomers), 7.047.12 (m, 2H), 7.137.37 (m, 12H), 7.487.55 (m, 2H), 7.657.72 (m, 2H). 13C NMR 
(100.6 MHz, CD2Cl2):  = 0.3 (CH2, maj), 1.3 (CH2, min), 2.8 (CH2, min), 3.2 (CH2, maj), 17.0 (CH3, 
maj), 17.8 (CH3, min), 18.8 (CH, min), 19.7 (CH, maj), 20.7 (CH3, maj), 21.1 (CH3, min), 30.7 (CH, 
maj), 30.9 (CH, min), 31.3 (CH3, min), 31.5 (CH3, maj), 40.6 (CH, maj), 41.2 (CH, min), 45.4 (C, min), 
45.5 (C, maj), 108.8 (CH, min), 108.9 (CH, maj), 111.1 (C, maj), 111.2 (C, min), 118.5 (CH, maj), 
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118.6 (CH, min), 119.3 (CH, min), 119.4 (CH, maj), 120.9 (CH, maj), 121.0 (CH, min), 124.8 (CH, 
min), 125.0 (CH, maj), 125.77 (C, maj), 125.84 (C, min), 126.3 (CH, min), 126.4 (CH, maj), 127.4 (2 × 
CH, min), 127.5 (2 × CH, maj), 128.5 (2 × CH, min), 128.6 (2 × CH, maj), 130.6 (CH, maj), 130.9 (CH, 
min), 137.8 (C, min), 137.9 (C, maj), 139.0 (C, maj), 139.2 (C, min), 147.5 (C, min), 147.6 (C, maj). 
LRMS (70 eV, EI): m/z (%) 341 (M
+
, 4), 298 (100), 257 (48). HRMS calcd for C25H27N, 341.2144; 
found, 341.2145. 
4-Cyclopropyl-9-methyl-1,4-diphenyl-4,9-dihydro-1H-carbazole (2j): Yellow solid; yield = 82% 
(154 mg) (Method A); isolated as a ~1:1.3 mixture of diastereoisomers; Rf = 0.23 (hexane/AcOEt, 20:1). 
1
H NMR (400 MHz, CD2Cl2):  = 0.220.40 (m, 3H), 0.420.52 (m, 1H), 0.590.70 (m, 2H), 0.710.95 
(m, 2H), 1.922.01 (m, 1H), 2.022.12 (m, 1H), 3.32 (s, 3H, maj), 3.36 (s, 3H, min), 4.804.84 (m, 1H, 
maj), 4.92 (dd, J = 4.0, 1.9 Hz, 1H, min), 5.40 (dd, J = 9.9, 1.9 Hz, 1H, min), 5.47 (dd, J = 9.9, 2.3 Hz, 
1H, maj), 5.83 (dd, J = 9.9, 3.4 Hz, 1H, maj), 5.92 (dd, J = 9.9, 4.0 Hz, 1H, min), 6.846.92 (m, 2H), 
7.077.14 (m, 2H), 7.157.40 (m, 20H, both isomers), 7.597.64 (m, 2H), 7.707.75 (m, 2H).13C NMR 
(100.6 MHz, CD2Cl2):  = 1.4 (CH2, maj), 2.1 (CH2, min), 2.90 (CH2, min), 2.92 (CH2, maj), 20.0 (CH, 
min), 20.9 (CH, maj), 30.1 (CH3, min), 30.4 (CH3, maj), 41.1 (CH, both isomers), 45.90 (C, maj), 45.94 
(C, min), 108.9 (CH, both isomers), 115.0 (C, maj), 116.1 (C, min), 118.6 (CH, both isomers), 120.1 
(CH, min), 120.3 (CH, maj), 121.0 (CH, both isomers), 125.1 (C, min), 125.2 (C, maj), 125.9 (CH, 
min), 126.1 (CH, maj), 126.8 (CH, min), 126.9 (CH, maj), 127.9 (CH, min), 127.96 (CH, maj), 127.97 
(4 × CH), 128.02 (4 × CH), 128.1 (2 × CH, min), 128.2 (2 × CH, maj), 129.0 (2 × CH, min), 129.1 (2 × 
CH, maj), 129.4 (CH, maj), 129.5 (CH, min), 134.1 (C, min), 134.8 (C, maj), 137.6 (C, min), 137.7 (C, 
maj), 143.0 (C, min), 143.2 (C, maj), 148.2 (C, maj), 148.4 (C, min). LRMS (70 eV, EI): isomer 1: m/z 
(%) 375 (M
+
, 57), 334 (100), 298 (12), 257 (21); isomer 2: m/z (%) 375 (M
+
, 64), 334 (100), 298 (34), 
257 (31). LRMS (70 eV, EI): m/z (%) 375 (M
+
, 61), 334 (100), 298 (30). HRMS calcd for C28H25N, 
375.1987; found, 375.1990. 
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9-Methyl-1,4,4-triphenyl-4,9-dihydro-1H-carbazole (2k): White solid; yield = 78% (160 mg) 
(Method A); M.p. 221223 ºC. 1H NMR (300 MHz, CD2Cl2):  = 3.41 (s, 3H), 4.92 (dd, J = 4.0, 1.9 Hz, 
1H), 6.00 (dd, J = 9.8, 4.0 Hz, 1H), 6.20 (dd, J = 9.8, 1.9 Hz, 1H), 6.836.92 (m, 1H), 7.067.41 (m, 
16H), 7.467.52 (m, 2H). 13C NMR (100.6 MHz, CD2Cl2):  = 30.1 (CH3), 41.1 (CH), 52.4 (C), 108.9 
(CH), 113.9 (C), 118.8 (CH), 120.8 (CH), 121.2 (CH), 125.6 (CH), 125.8 (C), 126.1 (CH), 126.3 (CH), 
126.9 (CH), 127.8 (2 × CH), 128.06 (2 × CH), 128.07 (2 × CH), 129.0 (2 × CH), 129.1 (2 × CH), 129.2 
(2 × CH), 134.6 (CH), 135.2 (C), 137.6 (C), 142.7 (C), 146.0 (C), 147.1 (C). LRMS (70 eV, EI): m/z 
(%) 411 (M
+
, 56), 334 (100), 319 (14). HRMS calcd for C31H25N, 411.1987; found, 411.1982. 
4-Cyclopropyl-1,9-dimethyl-1,4-diphenyl-4,9-dihydro-1H-carbazole (2l): White solid; yield = 
86% (167 mg) (Method A); isolated as a ~1:1.4 mixture of diastereoisomers; Rf = 0.22 (hexane/diethyl 
ether, 100:1). 
1
H NMR (400 MHz, CD2Cl2):  = 0.260.34 (m, 1H), 0.340.48 (m, 3H), 0.570.65 (m, 
1H), 0.660.73 (m, 1H), 0.730.87 (m, 2H), 1.901.99 (m, 1H), 1.99 (s, 3H, maj), 2.00 (s, 3H, min), 
2.072.16 (m, 1H), 3.28 (s, 3H, maj), 3.34 (s, 3H, min), 5.27 (d, J = 9.9 Hz, 1H, min), 5.36 (d, J = 9.8 
Hz, 1H, maj), 5.61 (d, J = 9.8 Hz, 1H, maj), 5.62 (d, J = 9.9 Hz, 1H, min), 6.846.93 (m, 2H), 
7.077.16 (m, 4H), 7.167.40 (m, 18H), 7.617.66 (m, 2H), 7.697.75 (m, 2H). 13C NMR (100.6 MHz, 
CD2Cl2): 1.7 (CH2, min), 1.9 (CH2, maj), 3.00 (CH2, min), 3.03 (CH2, maj), 20.1 (CH, min), 20.4 (CH, 
maj), 27.0 (CH3, maj), 27.1 (CH3, min), 31.1 (CH3, maj), 31.3 (CH3, min), 41.3 (C, maj), 41.6 (C, min), 
45.8 (C, min), 46.0 (C, maj), 108.88 (CH, maj), 108.92 (CH, min), 114.4 (C, maj), 115.5 (C, min), 
118.68 (CH, maj), 118.71 (CH, min), 120.2 (CH, min), 120.4 (CH, maj), 121.0 (CH, maj), 121.1 (CH, 
min), 124.9 (C, min), 125.1 (C, maj), 125.9 (CH, min), 126.0 (CH, min), 126.1 (CH, maj), 126.5 (2 × 
CH, min), 126.8 (2 × CH, maj), 127.0 (CH, maj), 127.9 (2 × CH, min), 128.05 (2 × CH, maj),128.09 (2 
× CH, min), 128.14 (2 × CH, maj), 128.7 (2 × CH, min), 128.8 (2 × CH, maj), 135.2 (CH, maj), 135.6 
(CH, min), 137.8 (C, maj), 138.0 (C, min), 138.4 (C, min), 139.1 (C, maj), 146.23 (C, min), 146.25 (C, 
maj), 148.3 (C, min), 148.4 (C, maj). LRMS (70 eV, EI): m/z (%) 389 (M
+
, 51), 348 (100). HRMS calcd 
for C29H27N, 389.2144; found, 389.2132. 
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4-Cyclopropyl-9-methyl-1,1,4-triphenyl-4,9-dihydro-1H-carbazole (2m): White solid; yield = 25% 
(41% conversion) (56 mg) (Method A); M.p. 184 ºC. 1H NMR (400 MHz, CD2Cl2):  = -0.14-
0.04 (m, 1H), 0.140.23 (m, 1H), 0.510.59 (m, 1H), 0.630.72 (m, 1H), 1.891.98 (m, 1H), 3.18 (s, 
3H), 5.44 (d, J = 9.8, 0.6 Hz, 1H), 6.07 (d, J = 9.8, 0.6 Hz, 1H), 6.846.89 (m, 1H), 7.077.15 (m, 2H), 
7.197.44 (m, 14H), 7.647.70 (m, 2H). 13C NMR (100.6 MHz, CD2Cl2):  = 1.4 (CH2), 3.2 (CH2), 
20.6 (CH), 32.0 (CH3), 45.7 (C), 51.3 (C), 109.0 (CH), 116.2 (C), 118.8 (CH), 120.6 (CH), 121.3 (CH), 
124.9 (C), 126.1 (CH), 126.7 (CH), 126.8 (CH), 127.3 (CH), 128.0 (2 × CH), 128.20 (2 × CH), 128.22 
(2 × CH), 128.3 (2 × CH), 129.2 (2 × CH), 129.5 (2 × CH), 134.8 (CH), 137.0 (C), 137.8 (C), 143.6 (C), 
144.5 (C), 148.3 (C). LRMS (70 eV, EI): m/z (%) 451 (M
+
, 70), 410 (100), 374 (15), 333 (28). HRMS 
calcd for C34H29N, 451.2300; found, 451.2300. 
4-Cyclopropyl-9-methyl-4-phenyl-4,9-dihydro-1H-carbazole (2n): Yellow solid; yield = 11% (16 
mg) (Method B); M.p. 100 ºC. 1H NMR (400 MHz, CD2Cl2):  = 0.220.30 (m, 1H), 0.310.39 
(m, 1H), 0.450.54 (m, 1H), 0.630.72 (m, 1H), 1.831.92 (m, 1H), 3.403.55 (m, 2H), 3.70 (s, 3H), 
5.54 (dt, J = 10.0, 2.2 Hz, 1H), 5.97 (dt, J = 10.0, 3.5 Hz, 1H), 6.796.84 (m, 1H), 6.987.03 (m, 1H), 
7.047.09 (m, 1H), 7.147.20 (m, 1H), 7.247.31 (m, 3H), 7.547.60 (m, 2H). 13C NMR (100.6 MHz, 
CD2Cl2):  = 1.6 (CH2), 2.3 (CH2), 20.1 (CH), 23.6 (CH2), 29.3 (CH3), 46.0 (C), 108.7 (CH), 113.2 (C), 
118.4 (CH), 119.7 (CH), 120.5 (CH), 121.2 (CH), 125.6 (C), 125.8 (CH), 127.9 (2 × CH), 128.0 (2 × 
CH), 132.6 (CH), 133.3 (C), 137.2 (C), 148.7 (C). LRMS (70 eV, EI): m/z (%) 299 (M
+
, 66), 270 (46), 
258 (100). HRMS calcd for C22H21N, 299.1674; found, 299.1676. 
1-Cyclopropyl-9-methyl-1-phenyl-4,9-dihydro-1H-carbazole (3n): White solid; yield = 60% (82 
mg) (Method B); M.p. 127 ºC. 1H NMR (300 MHz, CD2Cl2):  = 0.100.21 (m, 1H), 0.310.44 
(m, 1H), 0.750.86 (m, 2H), 1.701.81 (m, 1H), 3.30 (s, 3H), 3.403.60 (m, 2H), 5.32 (dt, J = 10.0, 2.2 
Hz, 1H), 6.02 (dt, J = 10.0, 3.4 Hz, 1H), 7.087.15 (m, 1H), 7.167.28 (m, 3H), 7.297.37 (m, 2H), 
7.417.47 (m, 2H), 7.547.60 (m, 1H). 13C NMR (75.4 MHz, CD2Cl2):  = 0.5 (CH2), 2.7 (CH2), 18.9 
(CH), 23.4 (CH2), 31.3 (CH3), 45.4 (C), 107.3 (C), 108.7 (CH), 118.1 (CH), 118.7 (CH), 121.1 (CH), 
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124.0 (CH), 126.25 (C), 126.34 (CH), 127.5 (2 × CH), 128.5 (2 × CH), 129.8 (CH), 137.5 (C), 138.4 
(C), 147.4 (C). LRMS (70 eV, EI): m/z (%) 299 (M
+
, 100), 258 (85), 243 (23). HRMS calcd for 
C22H21N, 299.1674; found, 299.1670. 
4,9-Dimethyl-4-phenyl-4,9-dihydro-1H-carbazole (2o): White solid; yield = 13% (18 mg) (Method 
B); M.p. 84 ºC. 1H NMR (400 MHz, CD2Cl2):  = 1.91 (s, 3H), 3.413.62 (m, 2H),
 
3.70 (s, 3H), 
5.81 (dt, J = 9.9, 2.0 Hz, 1H), 5.90 (dt, J = 9.9, 3.3 Hz, 1H), 6.826.91 (m, 1H), 7.057.18 (m, 3H), 
7.227.33 (m, 3H), 7.357.42 (m, 2H). 13C NMR (75.4 MHz, CD2Cl2):  = 23.5 (CH2), 26.7 (CH3), 29.3 
(CH3), 42.0 (C), 108.7 (CH), 114.7 (C), 118.3 (CH), 118.4 (CH), 119.4 (CH), 120.5 (CH), 125.3 (C), 
125.7 (CH), 127.1 (2 × CH), 128.0 (2 × CH), 132.6 (C), 137.3 (C), 137.9 (CH), 148.3 (C). LRMS (70 
eV, EI): m/z (%) 273 (M
+
, 30), 258 (100), 243 (21), 196 (24). HRMS calcd for C20H19N, 273.1517; 
found, 273.1519. 
1,9-Dimethyl-1-phenyl-4,9-dihydro-1H-carbazole (3o): White solid; yield = 63% (86 mg) (Method 
B); M.p. 159 ºC. 1H NMR (300 MHz, CD2Cl2):  = White solid; Rf 0.21 (hexane/diethyl ether, 
200:1). M.p. 159 ºC. 1H NMR (300 MHz, CD2Cl2):  = 1.90 (s, 3H), 3.27 (s, 3H), 3.463.67 (m, 
2H) , 5.63 (dt, J = 9.8, 2.2 Hz, 1H), 5.93 (dt, J = 9.8, 3.4 Hz, 1H), 7.087.36 (m, 8H), 7.557.60 (m, 
1H).
 13
C NMR (75.4 MHz, CD2Cl2):  = 23.4 (CH2), 25.9 (CH3), 31.0 (CH3), 41.5 (C), 106.9 (C), 108.6 
(CH), 118.2 (CH), 118.8 (CH), 120.3 (CH), 121.2 (CH), 126.2 (CH), 126.4 (C), 126.9 (2 × CH), 128.5 
(2 × CH), 136.3 (CH), 137.5 (C), 138.9 (C), 146.6 (C). LRMS (70 eV, EI): m/z (%) 273 (M
+
, 79), 258 
(100), 243 (23). HRMS calcd for C20H19N, 273.1517; found, 273.1518. 
4-Cyclopropyl-9-methyl-4-(thiophen-2-yl)-4,9-dihydro-1H-carbazole (2p): Yellow solid; yield = 
20% (31 mg) (Method A); M.p. 132 ºC. 1H NMR (300 MHz, CD2Cl2):  = 0.250.41 (m, 2H), 
0.500.71 (m, 2H), 1.942.05 (m, 1H), 3.353.55 (m, 2H), 3.69 (s, 3H), 5.64 (dt, J = 10.0, 2.2 Hz, 1H), 
5.96 (dt, J = 10.0, 3.5 Hz, 1H), 6.886.98 (m, 2H), 7.087.15 (m, 2H), 7.167.19 (m, 1H), 7.207.26 
(m, 1H), 7.287.34 (m, 1H). 13C NMR (100.6 MHz, CD2Cl2):  = 1.8 (CH2), 2.2 (CH2), 21.8 (CH), 23.6 
(CH2), 29.3 (CH3), 43.8 (C), 108.8 (CH), 112.8 (C), 118.6 (CH), 119.9 (CH), 120.6 (CH), 121.4 (CH), 
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123.8 (CH), 123.9 (CH), 125.7 (C),126.2 (CH), 132.1 (CH), 133.1 (C), 137.2 (C), 154.9 (C). LRMS (70 
eV, EI): m/z (%) 305 (M
+
, 85), 277 (21), 264 (100). HRMS calcd for C20H19NS, 305.1238; found, 
305.1230. 
1-Cyclopropyl-9-methyl-1-(thiophen-2-yl)-4,9-dihydro-1H-carbazole (3p): White solid; yield = 
40% (61 mg) (Method A); M.p. 124 ºC. 1H NMR (400 MHz, CD2Cl2):  = 0.190.27 (m, 1H), 
0.360.45 (m, 1H), 0.700.83 (m, 2H), 1.821.91 (m, 1H), 3.393.57 (m, 2H), 3.46 (s, 3H), 5.43 (dt, J 
= 9.9, 2.2 Hz, 1H), 6.04 (dt, J = 9.9, 3.4 Hz, 1H), 6.977.04 (m, 2H), 7.097.16 (m, 1H), 7.197.27 (m, 
2H), 7.287.32 (m, 1H), 7.557.59 (m, 1H). 13C NMR (100.6 MHz, CD2Cl2):  = 1.3 (CH2), 2.4 (CH2), 
20.5 (CH), 23.4 (CH2), 31.3 (CH3), 43.0 (C), 107.1 (C), 108.8 (CH), 118.4 (CH), 118.9 (CH), 121.5 
(CH), 124.1 (CH), 124.2 (CH), 124.6 (CH), 126.1 (C), 126.7 (CH), 129.6 (CH), 137.5 (C), 137.7 (C), 
153.1 (C). LRMS (70 eV, EI): m/z (%) 305 (M
+
, 74), 277 (47), 264 (100). HRMS calcd for C20H19NS, 
305.1238; found, 305.1239. 
9-Methyl-4,4-diphenyl-4,9-dihydro-1H-carbazole (2q): Yellow solid; yield = 24% (40 mg) 
(Method B); M.p. 205207 ºC. The compound was obtained slightly contaminated with indene 15. 1H 
NMR (400 MHz, CD2Cl2):  = 3.52 (dd, J = 3.5, 2.2 Hz, 2H), 3.71 (s, 3H), 6.06 (dt, J = 9.9, 3.5 Hz, 
1H), 6.22 (dt, J = 9.9, 2.2 Hz, 1H), 6.786.86 (m, 1H), 7.047.11 (m, 2H), 7.147.21 (m, 2H), 
7.227.37 (m, 9H). 13C NMR (100.6 MHz, CD2Cl2):  = 23.5 (CH2), 29.3 (CH3), 52.4 (C), 108.7 (CH), 
112.3 (C), 118.6 (CH), 119.5 (CH), 120.3 (CH), 120.7 (CH), 126.0 (2 × CH), 127.8 (4 × CH), 129.0 (4 
× CH), 133.4 (C), 136.9 (CH), 137.3 (C), 146.7 (2 × C). One quaternary carbon is not observed. LRMS 
(70 eV, EI): m/z (%) 335 (M
+
, 51), 258 (100), 243 (23), 144 (19). HRMS calcd for C25H21N, 335.1674; 
found, 335.1674.  
9-Methyl-1,1-diphenyl-4,9-dihydro-1H-carbazole (3q): White solid; yield = 37% (62 mg) (Method 
B); M.p. 213 ºC. 1H NMR (400 MHz, CD2Cl2):  = 3.16 (s, 3H), 3.60 (dd, J = 2.8, 1.5 Hz, 1H), 
6.05 (dt, J = 9.8, 2.8 Hz, 1H), 6.09 (dt, J = 9.8, 1.5 Hz, 1H), 7.117.16 (m, 1H), 7.177.30 (m, 4H), 
7.317.36 (m, 8H), 7.607.64 (m, 1H). 13C NMR (100.6 MHz, CD2Cl2):  = 23.3 (CH2), 31.7 (CH3), 
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51.8 (C), 108.1 (C), 108.8 (CH), 118.4 (CH), 118.9 (CH), 120.9 (CH), 121.5 (CH), 126.3 (C), 126.5 (2 × 
CH), 128.2 (4 × CH), 129.2 (4 × CH), 135.9 (CH), 136.8 (C), 137.5 (C), 144.3 (2 × C). LRMS (70 eV, 
EI): m/z (%) 335 (M
+
, 100), 258 (69), 243 (23). HRMS calcd for C25H21N, 335.1674; found, 335.1674. 
1-Methyl-3-((3-phenyl-1H-inden-1-yl)methyl)-1H-indole (15): Brown oil; yield = 13% (22 mg) 
(Method B); Rf = 0.25 (hexane/diethyl ether, 2:1). 
1
H NMR (400 MHz, CD2Cl2):  = 2.89 (ddd, J = 
14.4, 9.5, 0.7 Hz, 1H), 3.43 (ddd, J = 14.3, 6.2, 0.7 Hz, 1H), 3.77 (s, 3H), 3.934.00 (m, 1H), 6.58 (d, J 
= 2.1 Hz, 1H), 6.95 (bs, 1H), 7.097.15 (m, 1H), 7.217.29 (m, 2H), 7.297.39 (m, 3H), 7.417.47 (m, 
2H), 7.477.51 (m, 1H), 7.547.61 (m, 3H), 7.667.71 (m, 1H). 13C NMR (100.6 MHz, CD2Cl2):  = 
27.6 (CH2), 32.6 (CH3), 50.4 (CH), 109.3 (CH), 113.0 (C), 118.7 (CH), 119.0 (CH), 120.3 (CH), 121.5 
(CH), 123.6 (CH), 125.0 (CH), 126.5 (CH), 127.2 (CH), 127.6 (CH), 127.7 (2 × CH), 128.2 (C), 128.6 
(2 × CH), 136.1 (C), 136.9 (CH), 137.2 (C), 143.4 (C), 143.6 (C), 148.8 (C). LRMS (70 eV, EI): m/z 
(%) 335 (M
+
, 4), 144 (100). HRMS calcd for C25H21N, 335.1674; found, 335.1680. 
4,4-Dicyclopropyl-9-methyl-4,9-dihydro-1H-carbazole (2r): White foam; yield = 22% (29 mg) 
(Method B); Rf = 0.15 (hexane/diethyl ether, 100:1). 
1
H NMR (400 MHz, CD2Cl2):  = 0.180.30 (m, 
4H), 0.400.49 (m, 2H), 0.500.58 (m, 2H), 1.301.40 (m, 2H), 3.33 (dd, J = 3.4, 2.2 Hz, 2H), 3.63 (s, 
3H), 5.50 (dt, J = 10.2, 2.2 Hz, 1H), 5.92 (dt, J = 10.2, 3.4 Hz, 1H), 7.017.06 (m, 1H), 7.107.16 (m, 
1H), 7.277.32 (m, 1H), 7.837.89 (m, 1H). 13C NMR (100.6 MHz, CD2Cl2):  = 0.9 (2 × CH2), 1.7 (2 
× CH2), 19.9 (2 × CH), 23.8 (CH2), 29.2 (CH3), 40.3 (C), 108.7 (CH), 113.4 (C), 118.4 (CH), 120.2 
(CH), 120.8 (CH), 122.0 (CH), 126.2 (C), 131.0 (CH), 133.0 (C), 137.1 (C). LRMS (70 eV, EI): m/z (%) 
263 (M
+
, 46), 222 (100), 181 (46). HRMS calcd for C19H21N, 263.1674; found, 263.1674. 
1,1-Dicyclopropyl-9-methyl-4,9-dihydro-1H-carbazole (3r): Colourless oil; yield = 49% (64 mg) 
(Method B); Rf = 0.23 (hexane/diethyl ether, 100:1). 
1
H NMR (400 MHz, CD2Cl2):  = 0.140.24 (m, 
2H), 0.320.42 (m, 2H), 0.500.60 (m, 2H), 0.610.68 (m, 2H), 1.191.28 (m, 2H), 3.33 (dd, J = 3.3, 
2.2 Hz, 2H), 3.99 (s, 3H), 5.40 (dt, J = 10.1, 2.2 Hz, 1H), 6.03 (dt, J = 10.1, 3.3 Hz, 1H), 7.037.09 (m, 
1H), 7.157.21 (m, 1H), 7.297.34 (m, 1H), 7.437.47 (m, 1H). 13C NMR (100.6 MHz, CD2Cl2):  = 
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1.2 (2 × CH2), 3.0 (2 × CH2), 18.9 (2 × CH), 23.5 (CH2), 32.3 (CH3), 39.1 (C), 106.6 (C), 108.6 (CH), 
118.0 (CH), 118.6 (CH), 120.9 (CH), 124.8 (CH), 126.3 (C), 129.2 (CH), 137.6 (C), 139.3 (C). LRMS 
(70 eV, EI): m/z (%) 263 (M
+
, 57), 222 (100), 181 (49). HRMS calcd for C19H21N, 263.1674; found, 
263.1678. 
4-(4-Chlorophenyl)-9-methyl-1-propyl-4,9-dihydro-1H-carbazole (2s): Yellow oil; yield = 75% 
(126 mg) (Method A); isolated as a ~1:1.4 mixture of diastereoisomers; Rf = 0.22 (hexane/diethyl ether, 
100:1). 
1
H NMR (400 MHz, CD2Cl2):  = 0.93 (t, J = 7.3 Hz, 3H, maj), 1.01 (t, 7.3 Hz, 3H, min), 
1.091.26 (m, 1H), 1.291.57 (m, 3H), 1.722.05 (m, 4H), 3.653.86 (m, 2H, both isomers), 3.77 (s, 
6H, both isomers), 4.774.82 (m, 1H, maj), 4.844.89 (m, 1H, min), 5.886.02 (m, 4H, both isomers), 
6.846.99 (m, 3H), 7.077.36 (m, 13H). 13C NMR (100.6 MHz, CDCl3):  = 14.06 (CH3, maj), 14.06 
(CH3, min), 18.3 (CH2, maj), 19.6 (CH2, min), 30.1 (CH3, min), 30.2 (CH3, maj), 33.3 (CH, maj), 33.5 
(CH, min), 37.5 (CH2, maj), 38.7 (CH2, min), 41.5 (CH, min), 41.6 (CH, maj), 108.8 (CH, both isomers), 
109.0 (C, min), 109.9 (C, maj), 118.5 (CH, min), 118.7 (CH, maj), 118.9 (CH, min), 119.0 (CH, maj), 
120.8 (CH, maj), 121.0 (CH, min), 125.9 (C, maj), 126.1 (C, min), 126.8 (CH, maj), 127.0 (CH, min), 
128.46 (2 × CH, maj), 128.54 (2 × CH, min), 129.6 (2 × CH, min), 129.9 (2 × CH, maj), 129.9 (CH, 
min), 130.6 (CH, maj), 131.71 (C, min), 131.74 (C, maj), 136.9 (C), 137.5 (C), 137.6 (C, min), 137.7 
(C), 143.4 (C, min), 144.0 (C, maj). LRMS (70 eV, EI): isomer 1: m/z (%) 335 (M
+
, 37), 292 (100), 257 
(66); isomer 2: m/z (%) 335 (M
+
, 50), 304 (100). HRMS calcd for C22H22NCl, 335.1441; found, 
335.1435. 
4-(4-Chlorophenyl)-9-methyl-4,9-dihydro-1H-carbazole (2t): White solid; yield = 75% (110 mg) 
(Method A); M.p. 150 ºC. 1H NMR (400 MHz, CD2Cl2):  = 3.433.62 (m, 2H), 3.70 (s, 3H), 
4.814.90 m, 1H), 5.95 (ddt, J = 9.9, 3.2, 1.7 Hz, 1H), 6.01 (dtd, J = 9.9, 3.2, 1.7 Hz, 1H), 6.876.93 
(m, 1H), 7.037.08 (m, 1H), 7.097.16 (m, 1H), 7.197.23 (m, 2H), 7.247.27 (m, 2H), 7.287.32 (m, 
1H). 
13
C NMR (100.6 MHz, CD2Cl2):  = 23.6 (CH2), 29.3 (CH3), 41.3 (CH), 108.7 (CH), 109.0 (C), 
118.0 (CH), 118.6 (CH), 120.8 (CH), 121.3 (CH), 126.1 (C), 128.5 (2 × CH), 129.6 (2 × CH), 130.6 
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(CH), 131.7 (C), 133.5 (C), 137.2 (C), 144.0 (C). LRMS (70 eV, EI): m/z (%) 293 (M
+
, 100), 182 (59), 
167 (27). HRMS calcd for C19H16NCl, 293.0971; found, 293.0975. 
9-Methyl-4-(naphthalen-1-yl)-4,9-dihydro-1H-carbazole (2u): Yellow solid; yield = 74% (114 mg) 
(Method B); Rf = 0.32 (hexane/AcOEtr, 8:1). 
1
H NMR (300 MHz, CDCl3):  = 3.443.70 (m, 2H), 3.74 
(s, 3H), 5.025.12 (m, 1H), 5.956.12 m, 2H), 6.826.92 (m, 1H), 7.097.18 (m, 2H), 7.257.38 (m, 
2H), 7.387.51 (m, 2H), 7.707.88 (m, 4H). 13C NMR (75.4 MHz, CDCl3):  = 23.6 (CH2), 29.2 (CH3), 
42.1 (CH), 108.4 (CH), 109.3 (C), 118.7 (CH), 118.9 (CH), 120.7 (2 × CH), 125.1 (CH), 125.7 (CH), 
126.15 (CH), 126.19 (C), 126.7 (CH), 127.55 (CH), 127.62 (CH), 128.1 (CH), 131.2 (CH), 132.3 (C), 
133.1 (C), 133.5 (C), 137.0 (C), 142.3 (C). HRMS calcd for C23H19N, 309.1517; found, 309.1519. 
9-Methyl-1-phenyl-4,9-dihydro-1H-carbazole (2v): White solid; yield = 84% (109 mg) (Method A); 
M.p. 129 ºC. 1H NMR (400 MHz, CD2Cl2):  = 3.35 (s, 3H), 3.503.69 (m, 2H), 4.80 (tdd, J = 5.9, 
4.0, 1.7 Hz, 1H), 5.94 (ddt, J = 9.8, 4.0, 2.1 Hz, 1H), 6.05 (dtd, J = 9.8, 3.3, 1.7 Hz, 1H), 7.097.28 (m, 
6H), 7.287.34 (m, 2H), 7.58 (d, J = 7.7 Hz, 1H). 13C NMR (75.4 MHz, CD2Cl2):  = 23.6 (CH2), 29.8 
(CH3), 41.2 (CH), 107.4 (C), 108.7 (CH), 118.2 (CH), 118.7 (CH), 121.1 (CH), 123.5 (CH), 126.4 (C), 
126.6 (CH), 128.0 (2 × CH), 128.80 (CH), 128.82 (2 × CH), 134.9 (C), 137.2 (C), 143.6 (C). LRMS (70 
eV, EI): m/z (%) 259 (M
+
, 100), 258 (40), 182 (44), 167 (29). HRMS calcd for C19H17N, 259.1361; 
found, 259.1358. 
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